{"paper_id":"4091ecaa-fbdd-4d8f-93d0-21b4e54c2fdd","body_text":"Essential growth factor receptors for fibroblast... | F1000Research <!-- --> <!-- --> <!-- This is commented out to fix display problems on mobile devices. We may use it again once we implement a responsive design that supports native device resolutions. --> \"use strict\";function _typeof(t){return(_typeof=\"function\"==typeof Symbol&&\"symbol\"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&\"function\"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?\"symbol\":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement(\"iframe\");r.style.cssText=\"display:none\",r.name=\"__tcfapiLocator\",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r 3&&2===parseInt(n[1],10)&&\"boolean\"==typeof n[3]&&(e=n[3],\"function\"==typeof n[2]&&n[2](\"set\",!0)):\"ping\"===n[0]?\"function\"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:\"stub\"}):o.push(n)},n.addEventListener(\"message\",(function(t){var e=\"string\"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n=\"object\"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,\"*\")}),n.parameter)}),!1))};\"undefined\"!=typeof module?module.exports=t:t()}(); dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:[\"bam.nr-data.net\"]}}; ;NREUM.loader_config={accountID:\"438030\",trustKey:\"438030\",agentID:\"772317073\",licenseKey:\"97f8f67f26\",applicationID:\"772317073\"} ;NREUM.info={beacon:\"bam.nr-data.net\",errorBeacon:\"bam.nr-data.net\",licenseKey:\"97f8f67f26\",applicationID:\"772317073\",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{\"use strict\";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error(\"All info objects require an agent identifier!\");if(!a[e])throw new Error(\"Info for \".concat(e,\" was never set\"));return a[e]}function c(e,t){if(!e)throw new Error(\"All info objects require an agent identifier!\");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],\"info\")}var u=r(7056);const d=()=>{const e={blockSelector:\"[data-nr-block]\",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:\"*\",maskAllInputs:!0,get blockClass(){return\"nr-block\"},get ignoreClass(){return\"nr-ignore\"},get maskTextClass(){return\"nr-mask\"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=\",\".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error(\"All configuration objects require an agent identifier!\");if(!f[e])throw new Error(\"Configuration for \".concat(e,\" was never set\"));return f[e]}function h(e,t){if(!e)throw new Error(\"All configuration objects require an agent identifier!\");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],\"config\")}function g(e,t){if(!e)throw new Error(\"All configuration objects require an agent identifier!\");var r=l(e);if(r){for(var n=t.split(\".\"),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||\"object\"!=typeof e)return(0,n.Z)(\"Setting a Configurable requires an object as input\");if(!t||\"object\"!=typeof t)return(0,n.Z)(\"Setting a Configurable requires a model to set its initial properties\");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{\"object\"==typeof e[a]&&\"object\"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)(\"An error occurred while setting a property of a Configurable\",e)}return r}catch(e){(0,n.Z)(\"An error occured while setting a Configurable\",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n=\"1.236.0\",i=\"PROD\",o=\"CDN\"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n=\"undefined\"!=typeof window&&!!window.document,i=\"undefined\"!=typeof WorkerGlobalScope&&(\"undefined\"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||\"undefined\"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:\"undefined\"!=typeof WorkerGlobalScope&&(\"undefined\"!=typeof self&&self instanceof WorkerGlobalScope&&self||\"undefined\"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=\"\"+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&\"undefined\"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\\s](\\d+\\.\\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:\"\",ee:void 0};class o{constructor(e){try{if(\"object\"!=typeof e)return(0,n.Z)(\"shared context requires an object as input\");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)(\"An error occured while setting SharedContext\",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:\"\",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:\"feature\";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s=\"nr@context\";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&\"object\"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;f<d;f++)s[f].apply(a,r);var l=T()[c[e]];return l&&l.push([p,e,r,a]),a}}function b(e,t){n[e]=w(e).concat(t)}function y(e,t){var r=n[e];if(r)for(var i=0;i {r.d(t,{E:()=>n,p:()=>i});var n=r(2177).ee.get(\"handle\");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o=\"feature\"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener(\"test\",null,e),n._A.removeEventListener(\"test\",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i=\"xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx\";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split(\"\").map((e=>\"x\"===e?o(t,++r).toString(16):\"y\"===e?(3&o()|8).toString(16):e)).join(\"\")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n=\"NRBA\",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||\"\").indexOf(\"data:\"))return{protocol:\"data\"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement(\"a\"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split(\"://\");!o.port&&a[1]&&(o.port=a[1].split(\"/\")[0].split(\"@\").pop().split(\":\")[1]),o.port&&\"0\"!==o.port||(o.port=\"https\"===a[0]?\"443\":\"80\"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],\"/\"!==o.pathname.charAt(0)&&(o.pathname=\"/\"+o.pathname);var s=!t.protocol||\":\"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),\"/\"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){\"function\"==typeof console.warn&&(console.warn(\"New Relic: \".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&\"object\"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)(\"feat-\"+t,[],void 0,e,r):(0,i.p)(\"block-\"+t,[],void 0,e,r),(0,i.p)(\"rumresp-\"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)(\"feat-\"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)(\"rumresp-\"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if(\"object\"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit(\"internal-error\",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return\"undefined\"==typeof document||\"complete\"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)(\"load\",e,t)}function a(e){if(i())return e();(0,n.iz)(\"DOMContentLoaded\",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:\"bam.nr-data.net\",errorBeacon:\"bam.nr-data.net\"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)(\"visibilitychange\",(function(){if(t)return void(\"hidden\"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i=\"nr@original\";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n=\"\");var a,s,c,u=\"-\"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,\"fetch\",y),t.on(y+\"end\",(function(e,r){var n=this;if(r){var i=r.headers.get(\"content-length\");null!==i&&(n.rxSize=i),t.emit(y+\"done\",[null,r],n)}else t.emit(y+\"done\",[e],n)})),t}const O={},j=[\"pushState\",\"replaceState\"];function S(e){const t=function(e){return(e||n.ee).get(\"history\")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,\"-\")),t}var P=r(3239);const C={},R=[\"appendChild\",\"insertBefore\",\"replaceChild\"];function I(e){const t=function(e){return(e||n.ee).get(\"jsonp\")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\\.([^.]+)/,a=/^(\\w+)(\\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,\"dom-\"),t.on(\"dom-start\",(function(e){!function(e){if(!e||\"string\"!=typeof e.nodeName||\"script\"!==e.nodeName.toLowerCase())return;if(\"function\"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if(\"function\"!=typeof u.parent[u.key])return;var d={};function f(){t.emit(\"jsonp-end\",[],d),e.removeEventListener(\"load\",f,(0,P.m$)(!1)),e.removeEventListener(\"error\",l,(0,P.m$)(!1))}function l(){t.emit(\"jsonp-error\",[],d),t.emit(\"jsonp-end\",[],d),e.removeEventListener(\"load\",f,(0,P.m$)(!1)),e.removeEventListener(\"error\",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],\"cb-\",d),e.addEventListener(\"load\",f,(0,P.m$)(!1)),e.addEventListener(\"error\",l,(0,P.m$)(!1)),t.emit(\"new-jsonp\",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get(\"mutation\")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,\"fn-\")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get(\"promise\")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,\"executor-\",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,\"name\",{value:\"Promise\"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),[\"all\",\"race\"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a(\"all\"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit(\"propagate\",[null,!i],o,!1,!1),i=i||!e}}}})),[\"resolve\",\"reject\"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit(\"propagate\",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,[\"onreadystatechange\"],\"fn-\",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit(\"xhr-resolved\",[],e)),i.inPlace(e,f,\"fn-\",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,\"-xhr-\",E),r.on(\"send-xhr-start\",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on(\"open-xhr-start\",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on(\"fn-end\",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i=\"nr@seenError\"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i=\"sm\",o=\"cm\",a=\"storeSupportabilityMetrics\",s=\"storeEventMetrics\"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i=\"firstbyte\",o=\"domcontent\",a=\"windowload\"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i=\"bstResource\",o=\"resource\",a=\"-start\",s=\"-end\",c=\"fn\"+a,u=\"fn\"+s,d=\"pushState\"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=[\"click\",\"submit\",\"keypress\",\"keydown\",\"keyup\",\"change\"],a=999,s=\"fn-start\",c=\"fn-end\",u=\"cb-start\",d=\"api-ixn-\",f=\"remaining\",l=\"interaction\",h=\"spaNode\",g=\"jsonpNode\",p=\"fetch-start\",m=\"fetch-done\",v=\"fetch-body-\",b=\"jsonp-end\",y=n.Yu.ST,w=\"-start\",x=\"-end\",A=\"-body\",E=\"cb\"+x,T=\"jsTime\",_=\"fetch\"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();[\"setErrorHandler\",\"finished\",\"addToTrace\",\"inlineHit\",\"addRelease\",\"addPageAction\",\"setCurrentRouteName\",\"setPageViewName\",\"setCustomAttribute\",\"interaction\",\"noticeError\",\"setUserId\"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,\"api\");const h={};var g=a.ee.get(e),p=g.get(\"tracer\"),m=\"api-\",v=m+\"ixn-\";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?\"session\":void 0)(t,r)}function y(){}[\"setErrorHandler\",\"finished\",\"addToTrace\",\"inlineHit\",\"addRelease\"].forEach((e=>h[e]=x(m,e,!0,\"api\"))),h.addPageAction=x(m,\"addPageAction\",!0,n.D.pageAction),h.setCurrentRouteName=x(m,\"routeName\",!0,n.D.spa),h.setPageViewName=function(t,r){if(\"string\"==typeof t)return\"/\"!==t.charAt(0)&&(t=\"/\"+t),(0,i.OP)(e).customTransaction=(r||\"http://custom.transaction\")+t,x(m,\"setPageViewName\",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if(\"string\"==typeof e){if([\"string\",\"number\"].includes(typeof t)||null===t)return b(e,t,\"setCustomAttribute\",r);(0,f.Z)(\"Failed to execute setCustomAttribute.\\nNon-null value must be a string or number type, but a type of was provided.\"))}else(0,f.Z)(\"Failed to execute setCustomAttribute.\\nName must be a string type, but a type of was provided.\"))},h.setUserId=function(e){if(\"string\"==typeof e||null===e)return b(\"enduser.id\",e,\"setUserId\",!0);(0,f.Z)(\"Failed to execute setUserId.\\nNon-null value must be a string type, but a type of was provided.\"))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a=\"function\"==typeof t;return(0,o.p)(v+\"tracer\",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?\"\":\"no-\")+\"fn-start\",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit(\"fn-err\",[arguments,this,\"string\"==typeof e?new Error(e):e],r),e}finally{p.emit(\"fn-end\",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,[\"API/\"+t+\"/called\"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,\"api\")})).catch((()=>(0,f.Z)(\"Downloading runtime APIs failed...\")))}return[\"actionText\",\"setName\",\"setAttribute\",\"save\",\"ignore\",\"onEnd\",\"getContext\",\"end\",\"get\"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){\"string\"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,[\"API/noticeError/called\"],void 0,n.D.metrics,g),(0,o.p)(\"err\",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,\"api\"),(0,h.Qy)(e,A,\"exposed\"),(0,h.EZ)(\"activatedFeatures\",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:\"ajax\",jserrors:\"jserrors\",metrics:\"metrics\",pageAction:\"page_action\",pageViewEvent:\"page_view_event\",pageViewTiming:\"page_view_timing\",sessionReplay:\"session_replay\",sessionTrace:\"session_trace\",spa:\"spa\"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:\"page_action-aggregate\",147:\"metrics-aggregate\",242:\"session-manager\",317:\"jserrors-aggregate\",348:\"page_view_timing-aggregate\",412:\"lazy-feature-loader\",439:\"async-api\",538:\"recorder\",590:\"session_replay-aggregate\",675:\"compressor\",733:\"session_trace-aggregate\",786:\"page_view_event-aggregate\",873:\"spa-aggregate\",898:\"ajax-aggregate\"}[e]||e)+\".\"+{78:\"ac76d497\",147:\"3dc53903\",148:\"1a20d5fe\",242:\"2a64278a\",317:\"49e41428\",348:\"bd6de33a\",412:\"2f55ce66\",439:\"30bd804e\",538:\"1b18459f\",590:\"cf0efb30\",675:\"ae9f91a8\",733:\"83105561\",786:\"06482edd\",860:\"03a8b7a5\",873:\"e6b09d52\",898:\"998ef92b\"}[e]+\"-1.236.0.min.js\"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t=\"NRBA:\",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName(\"script\"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:\"timeout\",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{\"undefined\"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:\"Module\"}),Object.defineProperty(e,\"__esModule\",{value:!0})},i.j=364,i.p=\"https://js-agent.newrelic.com/\",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&(\"load\"===r.type?\"missing\":r.type),a=r&&r.target&&r.target.src;s.message=\"Loading chunk \"+t+\" failed.\\n(\"+o+\": \"+a+\")\",s.name=\"ChunkLoadError\",s.type=o,s.request=a,n[1](s)}}),\"chunk-\"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,\"\".concat(e,\".enabled\"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,\"privacy.cookies_enabled\");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)(\"A problem occurred when starting up session manager. This page will not start or extend any session.\",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,\"aggregate\");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)(\"Downloading and initializing \".concat(this.featureName,\" failed...\"),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,\"session_trace.enabled\")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),(\"undefined\"==typeof PerformanceNavigationTiming||c.Tt)&&\"undefined\"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)(\"timing\",[\"load\",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if(\"count\"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r=\"\",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean(\"hidden\"===document.visibilityState),(0,N.N)((()=>(0,s.p)(\"docHidden\",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)(\"pagehide\",(()=>(0,s.p)(\"winPagehide\",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem(\"__nr_flags\").split(\",\"),console&&\"function\"==typeof console.log&&(L.console=!0,-1!==R.indexOf(\"dev\")&&(L.dev=!0),-1!==R.indexOf(\"nr_dev\")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on(\"internal-error\",(function(e){z(e.stack)})),L.dev&&H.ee.on(\"fn-err\",(function(e,t,r){z(r.stack)})),L.dev&&(z(\"NR AGENT IN DEVELOPMENT MODE\"),z(\"flags: \"+(0,b.D)(L,(function(e,t){return e})).join(\", \")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on(\"fn-start\",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on(\"fn-err\",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)(\"err\",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on(\"fn-end\",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on(\"internal-error\",(function(t){(0,s.p)(\"ierr\",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener(\"unhandledrejection\",(t=>{const r=function(e){let t=\"Unhandled Promise Rejection: \";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)(\"err\",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){\"function\"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)(\"err\",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)(\"ierr\",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||\"Uncaught error with no additional information\",this.sourceURL=t,this.line=r}let U=1;const q=\"nr@id\";function G(e){const t=typeof e;return!e||\"object\"!==t&&\"function\"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if(\"string\"==typeof e&&e.length)return e.length;if(\"object\"==typeof e){if(\"undefined\"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if(\"undefined\"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!(\"undefined\"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||\"\").toString()||null,i=(r.agentID||\"\").toString()||null,o=(r.trustKey||\"\").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return\"00-\"+t+\"-\"+e+\"-01\"}generateTraceContextStateHeader(e,t,r,n,i){return i+\"@nr=0-1-\"+r+\"-\"+n+\"-\"+e+\"----\"+t}generateTraceHeader(e,t,r,n,i,o){if(!(\"function\"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:\"Browser\",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,\"distributed_tracing\")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener(\"load\",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener(\"progress\",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader(\"X-NewRelic-ID\",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader(\"newrelic\",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader(\"traceparent\",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader(\"tracestate\",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{\"abort\"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),(\"load\"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||\"function\"!=typeof t.onload)&&\"function\"==typeof o.end)&&o.end(t)}catch(e){try{n.emit(\"internal-error\",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set(\"newrelic\",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set(\"traceparent\",t.traceContextParentHeader),t.traceContextStateHeader&&e.set(\"tracestate\",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;\"string\"==typeof i?r=i:\"object\"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&\"object\"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(\"\"+(i&&i instanceof Y&&i.method||n.method||\"GET\")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,\"string\"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i(\"xhr\",[this.params,o,this.startTime,this.endTime,\"fetch\"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||\"agent\")),this.start()):(0,l.Z)(\"Failed to initial the agent. Could not determine the runtime environment.\")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t=\"features\";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)(\"\".concat(t.featureName,\" is enabled but one or more dependent features has been disabled (\").concat((0,D.P)(n),\"). This may cause unintended consequences or missing data...\")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)(\"Failed to initialize all enabled instrument classes (agent aborted) -\",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)(\"bst\",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)(\"bstHist\",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get(\"tracer\"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get(\"events\"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit(\"newURL\",[\"\"+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,\"xhr-resolved\"],this.featureName),f.buffer([ve],this.featureName),u.buffer([\"setTimeout\"+le,\"clearTimeout\"+fe,ve],this.featureName),d.buffer([ve,\"new-xhr\",\"send-xhr\"+fe],this.featureName),l.buffer([me+fe,me+\"-done\",me+he+fe,me+he+le],this.featureName),h.buffer([\"newURL\"],this.featureName),g.buffer([ve],this.featureName),s.buffer([\"propagate\",be,ge,\"executor-err\",\"resolve\"+fe],this.featureName),o.buffer([ve,\"no-\"+ve],this.featureName),a.buffer([\"new-jsonp\",\"cb-start\",\"jsonp-error\",\"jsonp-end\"],this.featureName),y(l,me+fe),y(l,me+\"-done\"),y(a,\"new-jsonp\"),y(a,\"jsonp-end\"),y(a,\"cb-start\"),h.on(\"pushState-end\",m),h.on(\"replaceState-end\",m),window.addEventListener(\"hashchange\",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener(\"load\",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener(\"popstate\",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:\"spa\"})})(),window.NRBA=o})(); window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://f1000research.com/js/vendor/ckeditor/' window.reactTheme = 'research'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is \"complete\" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event \"completion\" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', \"PixelInitialized\", {}); (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2318163,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); search file_upload Submit your research search menu close search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Open Data, Software and Code Guidelines Open Data and Accessible Source Materials Guidelines (HSS) Open Data, Software and Code Guidelines (PSE) Prepublication Checks Production Process Posters and Slides Guidelines Document Guidelines Article Processing Charges Peer Review Finding Article Reviewers About How it Works For Reviewers Our Advisors Policies Glossary FAQs For Developers Newsroom Contact My Research Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { \"@context\": \"https://schema.org\", \"@type\": \"ScholarlyArticle\", \"mainEntityOfPage\": { \"@type\": \"WebPage\", \"@id\": \"https://f1000research.com/articles/13-120\" }, \"headline\": \"Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor...\", \"datePublished\": \"2024-02-19T12:21:46\", \"dateModified\": \"2024-05-21T14:54:33\", \"author\": [ { \"@type\": \"Person\", \"name\": \"Maye F. Cheng\" }, { \"@type\": \"Person\", \"name\": \"Faizah S. Abdullah\" }, { \"@type\": \"Person\", \"name\": \"Matthew B. Buechler\" } ], \"publisher\": { \"@type\": \"Organization\", \"name\": \"F1000Research\", \"logo\": { \"@type\": \"ImageObject\", \"url\": \"https://f1000research.com/img/AMP/F1000Research_image.png\", \"height\": 480, \"width\": 60 } }, \"image\": { \"@type\": \"ImageObject\", \"url\": \"https://f1000research.com/img/AMP/F1000Research_image.png\", \"height\": 1200, \"width\": 150 }, \"description\": \"Fibroblasts are cells of mesenchymal origin that are found throughout the body. While these cells have several functions, their integral roles include maintaining tissue architecture through the production of key extracellular matrix components, and participation in wound healing after injury. Fibroblasts are also key mediators in disease progression during fibrosis, cancer, and other inflammatory diseases. Under these perturbed states, fibroblasts can activate into inflammatory fibroblasts or contractile myofibroblasts. Fibroblasts require various growth factors and mitogenic molecules for survival, proliferation, and differentiation. While the activity of mitogenic growth factors on fibroblasts in vitro was characterized as early as the 1970s, the proliferation and differentiation effects of growth factors on these cells in vivo are unclear. Recent work exploring the heterogeneity of fibroblasts raises questions as to whether all fibroblast cell states exhibit the same growth factor requirements. Here, we will examine and review existing studies on the influence of fibroblast growth factor receptors (FGFRs), platelet-derived growth factor receptors (PDGFRs), and transforming growth factor β receptor (TGFβR) on fibroblast cell states.\" } { \"@context\": \"http://schema.org\", \"@type\": \"BreadcrumbList\", \"itemListElement\": [ { \"@type\": \"ListItem\", \"position\": \"1\", \"item\": { \"@id\": \"https://f1000research.com/\", \"name\": \"Home\" } }, { \"@type\": \"ListItem\", \"position\": \"2\", \"item\": { \"@id\": \"https://f1000research.com/browse/articles\", \"name\": \"Browse\" } }, { \"@type\": \"ListItem\", \"position\": \"3\", \"item\": { \"@id\": \"https://f1000research.com/articles/13-120\", \"name\": \"Essential growth factor receptors for fibroblast homeostasis and activation:...\" } } ] } Home Browse Essential growth factor receptors for fibroblast homeostasis and activation:... ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article Cheng MF, Abdullah FS and Buechler MB. Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.12688/f1000research.143514.2 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Review Revised Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] Previously titled: Essential growth factor receptors for fibroblast homeostasis and activation Maye F. Cheng https://orcid.org/0000-0003-1902-622X 1 * , Faizah S. Abdullah https://orcid.org/0009-0008-9775-4015 1 * , Matthew B. Buechler https://orcid.org/0000-0003-1902-622X 1 Maye F. Cheng https://orcid.org/0000-0003-1902-622X 1 * , Faizah S. Abdullah https://orcid.org/0009-0008-9775-4015 1 * , Matthew B. Buechler https://orcid.org/0000-0003-1902-622X 1 * Equal contributors PUBLISHED 21 May 2024 Author details Author details 1 Immunology, University of Toronto, Toronto, ON, M5S 1A8, Canada Maye F. Cheng Roles: Conceptualization, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Faizah S. Abdullah Roles: Conceptualization, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Matthew B. Buechler Roles: Conceptualization, Funding Acquisition, Supervision, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing OPEN PEER REVIEW DETAILS REVIEWER STATUS This article is included in the Cell & Molecular Biology gateway. This article is included in the Advances in Fibroblast Research collection. Abstract Fibroblasts are cells of mesenchymal origin that are found throughout the body. While these cells have several functions, their integral roles include maintaining tissue architecture through the production of key extracellular matrix components, and participation in wound healing after injury. Fibroblasts are also key mediators in disease progression during fibrosis, cancer, and other inflammatory diseases. Under these perturbed states, fibroblasts can activate into inflammatory fibroblasts or contractile myofibroblasts. Fibroblasts require various growth factors and mitogenic molecules for survival, proliferation, and differentiation. While the activity of mitogenic growth factors on fibroblasts in vitro was characterized as early as the 1970s, the proliferation and differentiation effects of growth factors on these cells in vivo are unclear. Recent work exploring the heterogeneity of fibroblasts raises questions as to whether all fibroblast cell states exhibit the same growth factor requirements. Here, we will examine and review existing studies on the influence of fibroblast growth factor receptors (FGFRs), platelet-derived growth factor receptors (PDGFRs), and transforming growth factor β receptor (TGFβR) on fibroblast cell states. READ ALL READ LESS Keywords Fibroblasts, growth factors, growth factor receptors, FGFR, PDGFR, TGF-b Corresponding Author(s) Matthew B. Buechler ( [email protected] ) Close Corresponding author: Matthew B. Buechler Competing interests: No competing interests were disclosed. Grant information: This work was funded by the Canadian Institutes of Health Research (471606) Copyright: © 2024 Cheng MF et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: Cheng MF, Abdullah FS and Buechler MB. Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.12688/f1000research.143514.2 ) First published: 19 Feb 2024, 13 :120 ( https://doi.org/10.12688/f1000research.143514.1 ) Latest published: 21 May 2024, 13 :120 ( https://doi.org/10.12688/f1000research.143514.2 ) Revised Amendments from Version 1 In this version of the review, we updated the title to better reflect the growth factor receptors discussed and we also included additional references to address both reviewers' comments. Incorrectly numbered references have been corrected. Figure 2 was revised. In this version of the review, we updated the title to better reflect the growth factor receptors discussed and we also included additional references to address both reviewers' comments. Incorrectly numbered references have been corrected. Figure 2 was revised. See the authors' detailed response to the review by Michelle D Tallquist See the authors' detailed response to the review by Natalia Pikor READ REVIEWER RESPONSES Introduction Fibroblasts are non-hematopoietic cells of mesenchymal origin that are essential for the structural integrity of organs. These cells maintain tissue homeostasis and participate in diseases by secreting extracellular matrix (ECM) components and providing signalling cues for other cell types, including immune cells and other non-hematopoietic cells. 1 Fibroblasts are diverse and comprised of various context-specific cell states, including fibroblastic reticular cells (FRCs) in secondary lymphoid organs and peribronchial and alveolar fibroblasts in the lung. 2 , 3 The heterogeneity within fibroblasts across tissues may suggest that a progenitor-like population of fibroblasts exists within organs that can give rise to more specialized fibroblasts. 3 To this end, Buechler and Pradhan et al . demonstrated the presence of two fibroblast subsets expressing high levels of stemness-associated genes found across many tissues. 3 They termed these cell states as universal fibroblasts and proposed that these cells can give rise to more specialized fibroblasts, though this concept has not been unequivocally demonstrated experimentally. 3 It is also well-established that under certain conditions, such as injuries and cancer, fibroblasts can become activated into myofibroblasts and develop into cancer-associated fibroblasts (CAFs). 2 – 4 The phenotypic plurality of fibroblasts in both steady and diseased states highlights a challenging aspect in therapeutically targeting cells of the fibroblast lineage in fibrosis, cancer, and other inflammatory diseases. Further investigation of the signals and pathways involved in the homeostasis and activation of fibroblast subsets may open the possibility of specifically eradicating or modulating specific populations of fibroblasts. In this review, we will highlight the biology of three common growth factor receptors associated with fibroblasts and their implications for understanding fibroblasts in health and disease. Dermatopontin ( Dpt + ) fibroblasts may be a reservoir for specialized fibroblasts across tissues Studying fibroblasts has traditionally been difficult given the heterogeneity of the fibroblast populations within and between tissues and a general lack of specific fibroblast markers. 5 , 6 A greater appreciation for fibroblast heterogeneity emerged with the advent of single-cell RNA-sequencing (scRNAseq). 1 , 3 , 6 In a differential expression analysis of data from adult murine heart, skeletal muscle, colon, and urinary bladder, a short-list of commonly expressed fibroblast markers was identified. 6 A total of 45 shared genes were found to be expressed within fibroblasts from these tissues, including dermatopontin ( Dpt ) and Peptidase inhibitor 16 ( Pi16 ). 6 In a broader cross-tissue study using mouse scRNAseq data, Buechler and Pradhan et al. observed that two populations of fibroblasts expressing Pi16 or Collagen 15a1 (Col15a1) were present in majority of the tissues examined. 3 These populations both displayed greater levels of stemness-associated genes and showed an enrichment for Dpt expression. 3 Due to their ubiquity across tissues, Dpt- enriched fibroblasts were termed ‘universal fibroblasts’ 3 ( Figure 1 ). Figure 1. Dpt+ fibroblasts exhibit a stem-like phenotype with signals that support homeostasis during development and steady state. Under perturbed conditions, fibroblasts can activate to become myofibroblasts with disease-specific functions. Buechler and Pradhan et al . identified the presence of Dpt+ fibroblasts across multiple tissues. 3 These fibroblast cell states may be poised to function as early progenitors that can differentiate into various context-specific cells within the body, such as adipocytes, osteoblasts or myofibroblasts. The signals that support Dpt+ fibroblast homeostasis have yet to be uncovered, but members of the fibroblast growth factor receptor (FGFR) and platelet-derived growth factor receptor (PDGFR) family are found to be enriched in Dpt+ fibroblasts. 3 This may suggest that these signalling pathways are crucial for Dpt+ fibroblast proliferation and survival. Myofibroblasts are more contractile cells that can produce excessive amounts of ECM components, such as α-smooth muscle actin (α-SMA) and collagen, under disease conditions. 4 The transition of fibroblasts to activated myofibroblasts can be dependent on the signalling cascade triggered by transforming growth factor-β (TGF-β) stimulation. Myofibroblasts are vital in wound healing and repair, although constitutive overactivation of these cells may lead to fibrosis and other disease phenotypes. 7 , 8 The presence of these fibroblasts in healthy and perturbed mouse and human tissues suggested a potential lineage trajectory involving a reservoir of Dpt+ fibroblasts that could give rise to specialized and activated fibroblasts in the steady and diseased states, respectively. 3 This postulation of a universal fibroblast reservoir pool is further supported in studies examining the developmental lineage of fibroblast cell states. A study that conducted FRC-specific fate-mapping in mice identified periarterial progenitors that can give rise to splenic FRCs during embryonic development. 9 These embryonic progenitors express Ly6a and Pdgfrα, similar to the Dpt+ population identified by Buechler and Pradhan et al. 3 , 9 The presence of Ly6a and Cd34+ FRC progenitors can also be found in Peyer’s patches with the capability to replenish other FRC subsets. 10 Fibroblasts with this phenotype and similar progenitor-like functions were also proposed to exist in the splenic white pulp as assessed by scRNAseq. 11 Morphological and surface marker expression similarities between fibroblasts and mesenchymal stem/stromal cells (MSCs), a population of multipotent stem cells may prevent a clear distinction between these two cell types. 12 , 13 It has been suggested that fibroblasts represent aged MSCs or the two populations are the same, but transcriptomic analysis have proven that only distinct subsets of fibroblasts are indistinguishable from MSCs. 14 , 15 In a single-cell gene expression analysis examining the development of murine brown adipose tissue, Jun et al. identified a population of embryonic Dpp4+Pi16+ fibroblasts at the onset of adipogenic development that are capable of adipogenesis. 16 The authors posited that this population serves as a reserve progenitor population. 16 Interestingly, the differentiation of Pi16+ fibroblasts into adipocytes is akin to the adipogenic potential of MSCs. 17 However, further work is required to adequately define similarities and differences between MSCs and Pi16+ fibroblasts. Recent studies examining the fibroblast landscape in secondary lymphoid organs have also identified the presence of Pi16+ fibroblasts among other FRCs. 18 , 19 These studies suggest that Pi16+ fibroblasts may have immunomodulatory roles beyond functioning as a reservoir of precursor cells in the fibroblast lineage. Despite the presence of Dpt+ fibroblasts across tissues and the mounting evidence implicating their importance in the fibroblast lineage and immunity, the signals they require for homeostasis are still poorly understood ( Figure 1 ). Elucidating the growth factors that sustain or expand Dpt+ fibroblasts in vivo may help delineate their functional role across tissues. Growth factors and their signalling pathways are essential for physiological homeostasis and under pathological conditions Growth factors and associated signalling pathways are critical for the development of mammalian tissue and cellular regeneration. The definition of growth factors broadly includes secreted molecules that regulate the cell cycle or induce cell differentiation. 20 Many of these growth factors also require an interaction with their corresponding cell surface receptors to trigger an intracellular signal cascade. The resulting cellular responses would include proliferation, differentiation, and gene transcription 20 ( Figure 2 ). In addition to directly impacting cellular processes, growth factors can also contribute to wound healing and tissue regeneration through a bi-directional relationship with the ECM. 21 The ECM can release molecules, such as heparan sulfate proteoglycans (HSPGs), which have been shown to enhance the activity of growth factors and prevent their degradation. 22 , 23 Indirectly, the ECM can also sequester cells to elicit growth factor expression and response. 22 Reciprocally, growth factors, such as TGF-β, may modulate ECM composition by stimulating production of ECM components or increase matrix metalloproteinases synthesis for ECM degradation. 22 Figure 2. FGFR, PDGFR and TGF-β receptor signalling pathways facilitate varying context-specific downstream effects in Dpt+ fibroblasts and myofibroblasts. Binding of respective growth factors to FGFR and PDGFR would induce receptor dimerization and activation of downstream signalling pathways, including the RAS/MAPK, PI3K-PKB/Akt, PLCγ, and JAK/STAT cascades. 24 – 26 Under physiological conditions, these pathways promote cell growth, proliferation, and survival in fibroblast populations in a context-dependent manner. TGF-β receptors may initiate the cascading phosphorylation events via SMAD proteins to induce activation, migration, and collagen production in myofibroblasts under diseased states. 27 Crosstalk between PDGFR and TGF-β suggests a tightly regulated system for specific biological processes, such as proliferation and differentiation, in fibroblast populations. 28 Some of the main growth factor-dependent signalling pathways for fibroblasts are initiated by the binding of fibroblast growth factors (FGFs) and platelet-derived growth factors (PDGFs), among others including epidermal growth factors (EGFs), to their respective receptors. 29 These growth factors share similar downstream events involving the phosphorylation of the receptor and mediator proteins to activate combinations of intracellular signalling pathways. These conserved signalling pathways involve phosphoinositide-3-kinase protein kinase B/Akt (PI3K-PKB/Akt), the mitogen-activated protein kinase (MAPK), phospholipase C γ (PLC γ) cascades, and transcription factors that include the signal transducers and activators of transcription (STATs) or SMAD proteins 24 – 26 , 29 ( Figure 2 ). The subsequent biological effects of these growth factors are influenced by several parameters, including the concentration of the growth factor and the presence of other stimuli. 30 The different circumstances impacting growth factor signalling functions may depend on the specific tissue and cell type implicated. For example, a member of the FGF family, FGF2, can promote cell proliferation in cell types such as pancreatic stellate cells, neural crest cells and MSCs. 31 – 34 However, FGF2 is also found to play a role in endothelial cell migration and may promote osteocyte differentiation in MSCs. 35 – 37 The tissue and cell-specific activity of growth factors allow for more targeted biological functions under normal, physiological conditions. Growth factors are crucial for maintaining homeostasis under healthy conditions; however, they have also been implicated to elicit disease progression. For example, during the transformative process from normal cells to malignant cancer cells, numerous genetic mutations accumulate. 38 Usually, these mutations involve the loss of tumour suppressor gene functions or incite oncogene functions, which would eventually lead to failure of DNA repair mechanisms. 38 Once premalignant cells begin to accumulate these oncogenic mutations, they can proliferate and clonally expand by the activation of signalling pathways orchestrated by growth factors. 38 The expanded cancer cells would eventually migrate and penetrate adjacent tissues, contributing to metastases. During this epithelial-to-mesenchymal transition (EMT), malignant cells would engage the transcription of a mesenchymal genetic program, promoting a transition from exhibiting epithelial features to acquiring mobility as mesenchymal cells. 39 This progressive conversion is also supported and mediated by growth factors, such as TGF-β, FGF, and EGF. 38 In addition to signalling cancer cells directly, growth factors, such as TGF-β, can also influence the surrounding cancer microenvironment by enriching the presence of myofibroblasts and CAFs. 40 In later stages of disease, cancer cells depend on angiogenesis for metastasis and tumour growth, which is further stimulated by mitogenic growth factors including FGF and vascular endothelial growth factor (VEGF). 38 Growth factor-based therapeutic strategies for cancer, fibrosis, and other diseases may have systemic implications due to their wide range of effects in the body. The majority of transgenic animal models with genes eliminated from growth factor family members are embryonically or postnatally lethal. 38 Targeting components of aberrant pathways that are causing uncontrolled proliferation or differentiation rather than the growth factors themselves may be a more feasible therapeutic option. Therefore, abrogating the interacting growth factor receptors may provide more focused therapeutic targets. As the first point of contact in the signalling pathway and a key transducer of the mitogenic signal, disrupting receptor activation may yield a more specific response than targeting the downstream signalling cascades shared between multiple growth factors and pathways. Further investigating the biological implications of FGFRs, PDGFRs, and TGFβR on fibroblast homeostasis may augment the efficacy of current treatments for fibrotic diseases. Fibroblast growth factor receptors Fibroblast growth factors (FGFs) were first identified in the 1970s following the discovery that a macromolecule isolated from the pituitary and the brain enhanced the growth of 3T3 cells, a mouse fibroblast cell line. 41 Since its discovery, this macromolecule named a “fibroblast growth factor” has demonstrated its importance in mediating fundamental processes during embryonic development through to adulthood. 24 , 42 Currently, 23 different FGFs have been identified, with the majority signalling through one of four fibroblast growth factor receptors (FGFRs) – FGFR1, FGFR2, FGFR3, and FGFR4. 24 These highly conserved isoforms of FGFR vary based on alternative splicing of the transcripts. 42 The differences between each FGFR extracellular domain profoundly affect the specific ligand-binding ability of each receptor. 42 Additionally, it has been shown that the expression of FGFR isoforms is dependent on cell type and tissue. 42 For example, the FGFR2b isoform is only expressed in epithelial cells, while FGFR2c is exclusively expressed in mesenchymal cells. 42 Despite differences in FGFR isoform expression across cell types, FGFR signalling can be detected in all human tissues at varying levels. 43 Similar to other members of receptor tyrosine kinase (RTK) families, FGFRs are single-pass transmembrane proteins that dimerize upon FGF binding. 24 , 25 Canonical FGF signal transduction through FGFR is assisted by heparin and heparan sulfate proteoglycan cofactors. 23 Alternatively, activation of FGFR by endocrine FGFs require Klotho co-receptors as cofactors. 24 , 44 After dimerization and autophosphorylation of tyrosine residues in the cytoplasmic region of the receptor, various downstream signalling pathways activate ( Figure 2 ). Thus, initiating physiological functions including cellular proliferation and differentiation, angiogenesis, and wound healing. 26 Fibroblast growth factor receptors can induce proliferation and differentiation in fibroblast populations As potent mitogenic receptors, the FGFR signal transduction pathway is tightly regulated by a negative feedback loop under normal physiological conditions. 45 Under circumstances of aberrant FGFR activation, the resulting uncontrolled mitogenic effects contribute to 5-10% of all human cancers. 46 The ability of FGFR to induce proliferation and differentiation is suggested in many cell types, especially in fibroblasts, where it was first discovered. An example of FGFR’s role in proliferation is demonstrated from FGFR1 inhibition in MSCs. 47 The loss of FGFR1 signalling results in a decrease in MSC expansion, a complete halt in the cell cycle, and has a negative impact on early mesoderm development. 47 Taken together, these data suggest FGFR1 signalling may play a role in regulating stemness during proliferation and lineage-commitment in MSCs. 47 In models of adipogenesis, inhibition of FGFR1 leads to a decrease in both FGF-1-mediated proliferation and priming for differentiation in human adipose fibroblasts. 48 Similarly, Xu and Dai demonstrated that mice with a fibroblast-specific ablation of FGFR2 displayed a decrease in interstitial cell proliferation and apoptosis after being challenged with ischemia/reperfusion injury to induce kidney damage. 49 The improvement in kidney fibrosis in the FGFR2 knock-out mice suggests that this was observed due to the inhibition of kidney fibroblast proliferation and activation. 49 The mitogenic effects of FGFR signalling have been examined extensively, however, its pro-proliferative phenotype may be tissue and cell-specific. In a paper examining FGFR1 signalling in basal cells of adult mouse trachea, Balasooriya et al. reported that loss of FGFR1 signalling increased levels of lung basal cell proliferation. 50 This observation contrasts the previously reported mitogenic effects of FGFR signalling in fibroblasts. It is suggested that lack of FGFR1 signalling prevents post-translational activation of sprouty RTK signaling antagonist 2 (SPRY2), a protein known to inhibit intracellular signalling downstream of other RTKs in basal cells. 50 This finding affirms the complexity of examining individual growth factor receptors, where context-dependent and compensatory effects from other signalling pathways may prevent a clear phenotype from being observed. Future research on FGFR signalling should prioritize the development of mouse models that can selectively delete growth factor receptor expression on fibroblasts. This will better recapitulate and distill the effects of growth factor receptors and delineate tissue or cell-specific effects in an in vivo environment. The role of FGFR signalling in Dpt+ universal fibroblasts has yet to be addressed. However, the implications of FGFR signalling in early embryogenesis and their effects on MSC differentiation point to its importance for the homeostasis of fibroblast progenitor cells. 47 , 51 , 52 It is tempting to speculate that autocrine or paracrine FGF2 may enable self-renewal or homeostasis of tissue-wide progenitor fibroblast population in vivo , much like pathways that have been proposed to underlie MSC homeostasis. 47 , 51 , 52 Interestingly, Fgfr1 expression was uniquely enhanced in universal fibroblast clusters, but not other members of the FGFR family. 3 Therefore, a greater understanding of Dpt + fibroblast subsets may reveal differential Fgfr expression and further elucidate the signals required by these fibroblast progenitor cells in vivo. Platelet-derived growth factor receptors Platelet-derived growth factors, or PDGFs, have been shown to play an integral role in fibroblast biology. 53 – 56 It is now appreciated that there are five isoforms of PDGF: the four homodimers PDGF-AA, PDGF-BB, PDGF-CC, PDGF-DD, and the heterodimer PDGF-AB. 57 These ligands function by binding to two receptors, referred to as platelet-derived growth factor receptor-α (PDGFRα) and platelet-derived growth factor receptor-β (PDGFRβ), which are broadly expressed among mesenchymal cell types, including fibroblasts. 57 These receptors dimerize following ligand binding, allowing for autophosphorylation, signal transduction, and the invocation of ubiquitous signalling cascades, such as the JAK/STAT and PI3K/Akt pathways 58 , 59 ( Figure 2 ). In turn, PI3K/Akt signalling can recruit mediators that are involved in cellular proliferation and survival, such as intracellular components of the Erk/MAPK pathway 57 – 59 ( Figure 2 ). Initial purification of PDGFRα through the cloning of murine cDNA encoding the receptor identified conserved features, such as a transmembrane domain, extracellular cystine residues, and a tyrosine kinase domain. 60 The receptor may undergo a variety of post-translational modifications prior to its expression on the membrane, including O-linked oligosaccharide and ubiquitin addition. 60 After ligand binding and downstream signal transduction and amplification, both PDGFRα and PDGFRβ can moderate proliferation, differentiation, survival, and chemotaxis, among other key cellular effects. 53 , 57 – 59 Signalling through platelet-derived growth factor receptors promote fibroblast maintenance and proliferation In the mid-1970s, platelets from serum were found to enhance growth in 3T3 fibroblasts in vitro. 61 These factors, later identified as PDGFs, allow for cellular stimulation and subsequent proliferation upon binding to their receptors. 61 The implication of PDGFR signalling on fibroblast proliferation is demonstrated by transgenic mouse models with conditional knock-ins of PDGFRα. Primary embryonic fibroblasts isolated from murine embryos with constitutive PDGFRα signalling activity display greater proliferative ability compared to wild type embryos. 53 Additionally, adult mice with constitutive PDGFRα signalling display aberrant levels of fibroblast activity, including connective tissue hyperplasia and excessive ECM production. 53 The resulting fibrosis and tissue scarring phenotype signifies the importance of PDGFRα in supporting key fibroblast functions. 53 Animal models with deficient PDGFRα expression further support its importance for fibroblast maintenance and survival. In an inactive state, cardiac fibroblasts are often quiescent and undergo limited proliferation. 54 A tamoxifen-induced deletion of PDGFRα in cells expressing the cardiac fibroblast-specific transcription factor 21 ( Tcf21 mCrem ) results in a drastic loss in ventricular cardiac fibroblasts in vivo. 54 This implies the need for a basal level of PDGFRα signalling to maintain resident cardiac fibroblast populations. 54 It is hypothesized that basal levels of PDGFRα signalling may prevent apoptotic signals that would lead to cell death as represented by a reduction in cell numbers. 54 Asli et al. also reported that PDGFRα inhibition in a stem cell-like population of cardiac fibroblasts in vitro demonstrates limited rates of self-renewal. 55 However, an enhanced synthesis of ribosomal and ribosomal-related genes, such as Eif1 , Eif2s1 , and Eif4a1, is observed following in vivo PDGF-AB treatment. 55 Taken together, these data suggest that signalling via the PDGFRα pathway may prompt fibroblasts to exit quiescence and instead enter a translationally active state. In addition to promoting fibroblast biological processes in steady state, PDGFR signalling may play a role during wound healing. An inhibition of wound closure is observed in scratch-wound assays where dermal fibroblasts lack PDGFRβ expression. 56 This may suggest that PDGFRβ signalling is vital to fibroblast migration and proliferation. 56 Ex vivo stimulation of adipocyte precursor (AP) cells with PDGF-CC results in an increase in their proliferation, while in vivo injections of PDGF-CC-neutralizing antibodies decrease AP cell numbers. 62 While PDGF-CC is indispensable for the expansion of the AP cell population, it is not required for the development of other myofibroblast subsets during wound healing. 62 Shook et al. demonstrated that local injections of PDGF-CC-neutralizing antibodies in wounds does not result in significant changes in the proliferation of non-AP myofibroblast subsets, nor in general wound re-revascularization during healing. 62 Notably, the expansion of precursor fibroblast populations after PDGFR activation via PDGF-AB and PDGF-CC binding may imply the importance of PDGFR signalling in the Dpt+ fibroblast population. 55 , 62 To this end, transgenic animal models with selective ablation of PDGFR signalling in Dpt+ fibroblasts may elucidate the importance of this receptor on the proliferation, survival, and activation of universal fibroblasts. Altogether, downstream pathways stimulated through PDGFRα and β signalling may be essential for fibroblast precursor cell states to exit a state of quiescence and activate biological processes, such as cell proliferation, self-renewal, migration, and apoptosis. Fibroblasts depend on TGF-β receptor signalling for differentiation into myofibroblasts While fibroblasts participate in essential functions including ECM remodelling and structural support during homeostasis, they can also become activated and transform into myofibroblasts under diseased conditions. In this state, cells can produce several compounds, such as α-SMA, ECM fibers, and collagen. 7 The excessive production of these molecules can then further promote the activation of myofibroblasts in a positive feedback loop, resulting in an uncontrolled, pathological fibrotic state. 63 There is a drastic increase in ECM production following the establishment of myofibroblasts in the damaged tissue. 63 Following this, signals within the wound bed can either trigger the cells to transform into a fibrotic phenotype or enter a quiescent state and eventually commit apoptosis. 64 Loss of physical stresses would prompt the cells to undergo cell death, while persistent mechanical tension would promote hypertrophic scar formation through the inhibition of apoptosis. 64 , 65 Persistent collagen secretion and fibrotic activity can lead to excessive scar formation and conditions with high disease burdens, such as idiopathic pulmonary fibrosis. 66 There are several factors in the microenvironment that can stimulate the transition of conventional fibroblasts to activated myofibroblasts, including physical and biochemical stresses and ECM remodelling. 64 Microenvironmental changes during inflammation also lead to the recruitment and infiltration of immune cells and the subsequent release of cytokines, such as IL-4, IL-13, tumor necrosis factor-alpha (TNF-α), and TGF-β. 27 , 67 – 69 Members of the tumor necrosis super family (TNFSF), which include TNF-α (TNFSF2), are also known proinflammatory mediators with implications in promoting fibroblast activation and have been reviewed elsewhere. 70 , 71 It has been well-established that TGF-β is a crucial mediator in the transition from fibroblasts to myofibroblasts. TGF-β, which exists in three isoforms (TGF-β1, TGF-β2, and TGF-β3), activates homo- or heterodimeric complexes consisting of the type I TGF-β receptor (TβRI) and the type II TGF-β receptor (TβRII) 27 ( Figure 2 ). Subsequent transcriptional changes can be exerted through a cascade of phosphorylation events involving the SMAD protein family 27 ( Figure 2 ). Fibroblasts cultured in the presence of TGF-β have demonstrated increased levels of myofibroblast-associated molecules, such as α-SMA, procollagen I-α-1, and ED-A fibronectin. 72 , 73 Alternatively, human fibroblasts treated with TGF-β and Lovastatin, a TGF-β inhibitor, prevented the transition of fibroblasts to myofibroblasts. 74 The production of TGF-β and associated cytokines from proximal immune cells is a key contributor to the fibroblast to myofibroblast transition. The release of TGF-β and IL-4 from M2 macrophages in the surrounding environment induces a myofibroblast-specific transcriptional state through the phosphorylation of SMAD3 and the induction of the JAK/STAT and PI3K/Akt signalling cascades 67 ( Figure 2 ). Additionally, co-culture of macrophages with human vocal fold fibroblasts has been associated with increased levels of pro-fibrotic compounds, including type I collagen and α-SMA. 75 This observation complements the noted amplification of genes involved in ECM productions, including Acta2 and Col1a1 . 75 The co-culture of fibroblasts with eosinophils also increased the expression of α-SMA through the stimulation of latent TGF-β and upregulated the transcription of fibronectin and collagen; thus, inducing the fibroblast to myofibroblast transition. 76 , 77 In addition to TGF-β mediating the transition of fibroblasts to myofibroblasts, PDGFR signalling may also activate fibroblasts in a context-dependent manner. The overexpression of PDGFR ligands, PDGF-AA and PDGF-BB, has demonstrated varying severity of cardiac fibrotic phenotypes in murine models. 78 This difference in fibrotic phenotypes may be due to the variation in binding affinity between the ligands and PDGFRα. 78 Furthermore, the loss of PDGFRα and PDGFRβ in transgenic murine models results in a reduction in the number of differentiated epicardial-derived cardiac fibroblasts, suggesting that PDGFR signalling is essential for the differentiation and activation of fibroblast subsets. 78 , 79 These data indicate that TGF-β may behave in a morphogenic fashion, with its levels balancing myofibroblast and tissue-specific fibroblast levels within the body. 28 TGF-β may act in a negative feedback loop with PDGFRα to prevent negative fibrotic outcomes. Increased levels of TGF-β favour myofibroblast differentiation, thus a corresponding decrease in PDGFR expression may limit potential fibrosis driven by fibroblast proliferation. As such, it would be valuable to explore the effects of TGF-β on Dpt+ fibroblasts and elucidate the potential crosstalk between TGF-β and PDGFR or other growth factor receptors on this fibroblast cell state. Conclusion Fibroblasts are found throughout organs across species, yet knowledge of these cells remain elusive. Recent scRNA-seq approaches have suggested that a hierarchy of transcriptional cell states exist within the fibroblast lineage. The role of growth factor receptors in proliferation and maintenance of various cell types is well-characterized, but their functions in discrete fibroblasts cell states remain unclear. Transgenic animal models with modified or eliminated growth factor receptor expressions in fibroblast subsets would be valuable for deciphering the signals required by fibroblasts under different conditions. However, the downstream signalling cascades of receptor tyrosine kinases are commonly shared by multiple growth factor receptors. This can pose challenges in isolating effects from individual growth factor receptors when examining signalling requirements for fibroblasts in in vitro and in vivo models. Furthermore, current literature provides an extensive catalog of growth factor receptors and activation signals that may have implications in fibroblast maintenance and differentiation. In this review, three common growth factor receptors associated with fibroblast homeostasis were explored, but this does not dismiss the contribution of other signalling pathways, which should be addressed in future studies. Nonetheless, exploring growth factor receptor signalling activity within the cell states that comprise the fibroblast lineage will promote the development of more specific and targeted therapies for cancer, fibrosis, and other inflammatory diseases. Data availability No data are associated with this article. References 1. Plikus MV, et al. : Fibroblasts: Origins, definitions, and functions in health and disease. Cell. 2021; 184 : 3852–3872. PubMed Abstract | Publisher Full Text | Free Full Text 2. Sherman MH, di Magliano MP : Cancer-Associated Fibroblasts: Lessons from Pancreatic Cancer. Annu. Rev. Cancer Biol. 2023; 7 : 43–55. Publisher Full Text 3. Buechler MB, et al. : Cross-tissue organization of the fibroblast lineage. Nature. 2021; 593 : 575–579. PubMed Abstract | Publisher Full Text 4. Otranto M, et al. : The role of the myofibroblast in tumor stroma remodeling. Cell Adhes. Migr. 2012; 6 : 203–219. PubMed Abstract | Publisher Full Text | Free Full Text 5. Janmaat CJ, et al. : Human Dermal Fibroblasts Demonstrate Positive Immunostaining for Neuron- and Glia- Specific Proteins. PLoS One. 2015; 10 : e0145235. PubMed Abstract | Publisher Full Text | Free Full Text 6. Muhl L, et al. : Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination. Nat. Commun. 2020; 11 : 3953. PubMed Abstract | Publisher Full Text | Free Full Text 7. D’Urso M, Kurniawan NA: Mechanical and Physical Regulation of Fibroblast–Myofibroblast Transition: From Cellular Mechanoresponse to Tissue Pathology. Front. Bioeng. Biotechnol. 2020; 8 : 609653. PubMed Abstract | Publisher Full Text | Free Full Text 8. Younesi FS, Miller AE, Barker TH, et al. : Fibroblast and myofibroblast activation in normal tissue repair and fibrosis. Nat. Rev. Mol. Cell Biol. 2024; 1–22 . PubMed Abstract | Publisher Full Text 9. Cheng H-W, et al. : Origin and differentiation trajectories of fibroblastic reticular cells in the splenic white pulp. Nat. Commun. 2019; 10 : 1739. PubMed Abstract | Publisher Full Text | Free Full Text 10. Prados A, et al. : Fibroblastic reticular cell lineage convergence in Peyer’s patches governs intestinal immunity. Nat. Immunol. 2021; 22 : 510–519. PubMed Abstract | Publisher Full Text | Free Full Text 11. Alexandre YO, et al. : A diverse fibroblastic stromal cell landscape in the spleen directs tissue homeostasis and immunity. Sci. Immunol. 2022; 7 : eabj0641. PubMed Abstract | Publisher Full Text 12. Bae S, et al. : Gene and microRNA expression signatures of human mesenchymal stromal cells in comparison to fibroblasts. Cell Tissue Res. 2008; 335 : 565. 13. Denu RA, et al. : Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable. Acta Haematol. 2016; 136 : 85–97. PubMed Abstract | Publisher Full Text | Free Full Text 14. Budeus B, Unger K, Hess J, et al. : Comparative computational analysis to distinguish mesenchymal stem cells from fibroblasts. Front. Immunol. 2023; 14 : 1270493. PubMed Abstract | Publisher Full Text | Free Full Text 15. Fan C, et al. : Single-Cell Transcriptome Integration Analysis Reveals the Correlation Between Mesenchymal Stromal Cells and Fibroblasts. Front. Genet. 2022; 13 : 798331. PubMed Abstract | Publisher Full Text | Free Full Text 16. Jun S, et al. : Control of murine brown adipocyte development by GATA6. Dev. Cell. 2023; 58 : 2195–2205.e5. PubMed Abstract | Publisher Full Text 17. Kim J, Ko J: A novel PPARγ2 modulator sLZIP controls the balance between adipogenesis and osteogenesis during mesenchymal stem cell differentiation. Cell Death Differ. 2014; 21 : 1642–1655. PubMed Abstract | Publisher Full Text | Free Full Text 18. Martin AD, et al. : PI16+ reticular cells in human palatine tonsils govern T cell activity in distinct subepithelial niches. Nat. Immunol. 2023; 24 : 1138–1148. PubMed Abstract | Publisher Full Text | Free Full Text 19. Lütge M, et al. : Conserved stromal–immune cell circuits secure B cell homeostasis and function. Nat. Immunol. 2023; 24 : 1149–1160. PubMed Abstract | Publisher Full Text | Free Full Text 20. Stone WL, Leavitt L, Varacallo M: Physiology, Growth Factor. StatPearls. 2023. 21. Kulebyakin KY, Nimiritsky PP, Makarevich PI: Growth Factors in Regeneration and Regenerative Medicine: “the Cure and the Cause.”. Front. Endocrinol. 2020; 11 : 384. PubMed Abstract | Publisher Full Text | Free Full Text 22. Schultz GS, Wysocki A: Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen. 2009; 17 : 153–162. Publisher Full Text 23. Sarrazin S, Lamanna WC, Esko JD: Heparan Sulfate Proteoglycans. Cold Spring Harb. Perspect. Biol. 2011; 3 : a004952. 24. Hui Q, Jin Z, Li X, et al. : FGF Family: From Drug Development to Clinical Application. Int. J. Mol. Sci. 2018; 19 : 1875. PubMed Abstract | Publisher Full Text | Free Full Text 25. Sarabipour S, Hristova K: Mechanism of FGF receptor dimerization and activation. Nat. Commun. 2016; 7 : 10262. PubMed Abstract | Publisher Full Text | Free Full Text 26. Furdui CM, Lew ED, Schlessinger J, et al. : Autophosphorylation of FGFR1 Kinase Is Mediated by a Sequential and Precisely Ordered Reaction. Mol. Cell. 2006; 21 : 711–717. PubMed Abstract | Publisher Full Text 27. Attisano L, Wrana JL: Signal Transduction by the TGF-β Superfamily. Science. 2002; 296 : 1646–1647. Publisher Full Text 28. Contreras O, et al. : Cross-talk between TGF-β and PDGFRα signaling pathways regulates the fate of stromal fibro–adipogenic progenitors. J. Cell Sci. 2019; 132 : jcs232157. 29. Rodrigues M, Griffith LG, Wells A: Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res. Ther. 2010; 1 : 32. PubMed Abstract | Publisher Full Text | Free Full Text 30. Cross M, Dexter TM: Growth factors in development, transformation, and tumorigenesis. Cell. 1991; 64 : 271–280. Publisher Full Text 31. Coleman SJ, et al. : Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion. EMBO Mol. Med. 2014; 6 : 467–481. PubMed Abstract | Publisher Full Text | Free Full Text 32. Murphy M, Reid K, Ford M, et al. : FGF2 regulates proliferation of neural crest cells, with subsequent neuronal differentiation regulated by LIF or related factors. Development. 1994; 120 : 3519–3528. Publisher Full Text 33. Teixeira BL, Amarante-Silva D, Visoni SB, et al. : FGF2 Stimulates the Growth and Improves the Melanocytic Commitment of Trunk Neural Crest Cells. Cell. Mol. Neurobiol. 2020; 40 : 383–393. PubMed Abstract | Publisher Full Text 34. Ahn H-J, Lee W-J, Kwack K, et al. : FGF2 stimulates the proliferation of human mesenchymal stem cells through the transient activation of JNK signaling. FEBS Lett. 2009; 583 : 2922–2926. PubMed Abstract | Publisher Full Text 35. Byun MR, et al. : FGF2 stimulates osteogenic differentiation through ERK induced TAZ expression. Bone. 2014; 58 : 72–80. PubMed Abstract | Publisher Full Text 36. Michaelis UR: Mechanisms of endothelial cell migration. Cell. Mol. Life Sci. 2014; 71 : 4131–4148. Publisher Full Text 37. Xiao L, et al. : Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells. Bone. 2010; 47 : 360–370. PubMed Abstract | Publisher Full Text | Free Full Text 38. Witsch E, Sela M, Yarden Y: Roles for Growth Factors in Cancer Progression. Physiology. 2010; 25 : 85–101. PubMed Abstract | Publisher Full Text | Free Full Text 39. Roche J: The Epithelial-to-Mesenchymal Transition in Cancer. Cancers. 2018; 10 : 52. PubMed Abstract | Publisher Full Text | Free Full Text 40. Kalluri R: The biology and function of fibroblasts in cancer. Nat. Rev. Cancer. 2016; 16 : 582–598. Publisher Full Text 41. Gospodarowicz D: Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature. 1974; 249 : 123–127. PubMed Abstract | Publisher Full Text 42. Eswarakumar VP, Lax I, Schlessinger J: Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005; 16 : 139–149. Publisher Full Text 43. Hughes SE: Differential Expression of the Fibroblast Growth Factor Receptor (FGFR) Multigene Family in Normal Human Adult Tissues. J. Histochem. Cytochem. 1996; 45 : 1005–1019. Publisher Full Text 44. Liu G, et al. : Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment. Cell Prolif. 2021; 54 : e13009. PubMed Abstract | Publisher Full Text | Free Full Text 45. Szybowska P, Kostas M, Wesche J, et al. : Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling. Cells. 2021; 10 : 1342. PubMed Abstract | Publisher Full Text | Free Full Text 46. Xian W, Schwertfeger KL, Vargo-Gogola T, et al. : Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model. J. Cell Biol. 2005; 171 : 663–673. PubMed Abstract | Publisher Full Text | Free Full Text 47. Dombrowski C, et al. : FGFR1 Signaling Stimulates Proliferation of Human Mesenchymal Stem Cells by Inhibiting the Cyclin-Dependent Kinase Inhibitors p21Waf1 and p27Kip1. Stem Cells. 2013; 31 : 2724–2736. PubMed Abstract | Publisher Full Text | Free Full Text 48. Widberg CH, et al. : Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes. Am. J. Physiol.-Endocrinol. Metab. 2009; 296 : E121–E131. PubMed Abstract | Publisher Full Text 49. Xu Z, Dai C: Ablation of FGFR2 in Fibroblasts Ameliorates Kidney Fibrosis after Ischemia/Reperfusion Injury in Mice. Kidney Dis. 2017; 3 : 160–170. PubMed Abstract | Publisher Full Text | Free Full Text 50. Balasooriya GI, Johnson J-A, Basson MA, et al. : An FGFR1-SPRY2 Signaling Axis Limits Basal Cell Proliferation in the Steady-State Airway Epithelium. Dev. Cell 2016; 37 : 85–97. PubMed Abstract | Publisher Full Text | Free Full Text 51. Dorey K, Amaya E: FGF signalling: diverse roles during early vertebrate embryogenesis. Development. 2010; 137 : 3731–3742. PubMed Abstract | Publisher Full Text | Free Full Text 52. Kähkönen TE, et al. : Role of fibroblast growth factor receptors (FGFR) and FGFR like-1 (FGFRL1) in mesenchymal stromal cell differentiation to osteoblasts and adipocytes. Mol. Cell. Endocrinol. 2018; 461 : 194–204. PubMed Abstract | Publisher Full Text 53. Olson LE, Soriano P: Increased PDGFRα Activation Disrupts Connective Tissue Development and Drives Systemic Fibrosis. Dev. Cell. 2009; 16 : 303–313. PubMed Abstract | Publisher Full Text | Free Full Text 54. Ivey MJ, Kuwabara JT, Riggsbee KL, et al. : Platelet-derived growth factor receptor-α is essential for cardiac fibroblast survival. Am. J. Physiol.-Hear. Circ. Physiol. 2019; 317 : H330–H344. PubMed Abstract | Publisher Full Text | Free Full Text 55. Asli NS, et al. : PDGFRα signaling in cardiac fibroblasts modulates quiescence, metabolism and self-renewal, and promotes anatomical and functional repair. bioRxiv. 2019; 225979. Publisher Full Text 56. Gao Z, et al. : Deletion of the PDGFR-β Gene Affects Key Fibroblast Functions Important for Wound Healing. J. Biol. Chem. 2005; 280 : 9375–9389. PubMed Abstract | Publisher Full Text 57. Heldin C-H: Targeting the PDGF signaling pathway in tumor treatment. Cell Commun. Signal. 2013; 11 : 97. PubMed Abstract | Publisher Full Text | Free Full Text 58. Masamune A, Satoh M, Kikuta K, et al. : Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells. World J. Gastroenterol. 2005; 11 : 3385–3391. PubMed Abstract | Publisher Full Text | Free Full Text 59. Heldin C-H, Östman A, Rönnstrand L: Signal transduction via platelet-derived growth factor receptors. Biochim. Biophys. Acta (BBA) - Rev. Cancer. 1998; 1378 : F79–F113. Publisher Full Text 60. Yarden Y, et al. : Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature. 1986; 323 : 226–232. PubMed Abstract | Publisher Full Text 61. Kohler N, Lipton A: Platelets as a source of fibroblast growth-promoting activity. Exp. Cell Res. 1974; 87 : 297–301. PubMed Abstract | Publisher Full Text 62. Shook BA, et al. : Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair. Science. 2018; 362 (6417): eaar2971. PubMed Abstract | Publisher Full Text | Free Full Text 63. Wu J-J, et al. : The ASIC3-M-CSF-M2 macrophage-positive feedback loop modulates fibroblast-to-myofibroblast differentiation in skin fibrosis pathogenesis. Cell Death Dis. 2022; 13 : 527. PubMed Abstract | Publisher Full Text | Free Full Text 64. Grinnell F, Zhu M, Carlson MA, et al. : Release of Mechanical Tension Triggers Apoptosis of Human Fibroblasts in a Model of Regressing Granulation Tissue. Exp. Cell Res. 1999; 248 : 608–619. PubMed Abstract | Publisher Full Text 65. Aarabi S, et al. : Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J. 2007; 21 : 3250–3261. Publisher Full Text 66. Wynn TA: Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 2011; 208 : 1339–1350. PubMed Abstract | Publisher Full Text | Free Full Text 67. Sheng J, et al. : M2 macrophage-mediated interleukin-4 signalling induces myofibroblast phenotype during the progression of benign prostatic hyperplasia. Cell Death Dis. 2018; 9 : 755. PubMed Abstract | Publisher Full Text | Free Full Text 68. Hashimoto S, Gon Y, Takeshita I, et al. : IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase–dependent pathway. J. Allergy Clin. Immunol. 2001; 107 : 1001–1008. PubMed Abstract | Publisher Full Text 69. Voulgari PV, et al. : Role of Cytokines in the Pathogenesis of Anemia of Chronic Disease in Rheumatoid Arthritis. Clin. Immunol. 1999; 92 : 153–160. PubMed Abstract | Publisher Full Text 70. Croft M, et al. : TNF superfamily in inflammatory disease: translating basic insights. Trends Immunol. 2012; 33 : 144–152. 71. Steele H, et al. : TNF superfamily control of tissue remodeling and fibrosis. Front. Immunol. 2023; 14 : 1219907. PubMed Abstract | Publisher Full Text | Free Full Text 72. Amara N, et al. : NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts. Thorax. 2010; 65 : 733–738. PubMed Abstract | Publisher Full Text | Free Full Text 73. Serini G, et al. : The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1. J. Cell Biol. 1998; 142 : 873–881. PubMed Abstract | Publisher Full Text | Free Full Text 74. Meyer-Ter-Vehn T, Katzenberger B, Han H, et al. : Lovastatin inhibits TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Investig. Ophthalmol. Vis. Sci. 2008; 49 : 3955–3960. Publisher Full Text 75. Nakamura R, Bing R, Gartling GJ, et al. : Macrophages alter inflammatory and fibrotic gene expression in human vocal fold fibroblasts. Exp. Cell Res. 2022; 419 : 113301. PubMed Abstract | Publisher Full Text 76. Janulaityte I, et al. : Asthmatic Eosinophils Alter the Gene Expression of Extracellular Matrix Proteins in Airway Smooth Muscle Cells and Pulmonary Fibroblasts. Int. J. Mol. Sci. 2022; 23 : 4086. PubMed Abstract | Publisher Full Text | Free Full Text 77. Kuwabara Y, et al. : Role of Matrix Metalloproteinase-2 in Eosinophil-Mediated Airway Remodeling. Front. Immunol. 2018; 9 : 2163. PubMed Abstract | Publisher Full Text | Free Full Text 78. Gallini R, Lindblom P, Bondjers C, et al. : PDGF-A and PDGF-B induces cardiac fibrosis in transgenic mice. Exp. Cell Res. 2016; 349 : 282–290. PubMed Abstract | Publisher Full Text 79. Smith CL, Baek ST, Sung CY, et al. : Epicardial-Derived Cell Epithelial-to-Mesenchymal Transition and Fate Specification Require PDGF Receptor Signaling. Circ. Res. 2011; 108 : e15–e26. Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 19 Feb 2024 ADD YOUR COMMENT Comment Author details Author details 1 Immunology, University of Toronto, Toronto, ON, M5S 1A8, Canada Maye F. Cheng Roles: Conceptualization, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Faizah S. Abdullah Roles: Conceptualization, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Matthew B. Buechler Roles: Conceptualization, Funding Acquisition, Supervision, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information This work was funded by the Canadian Institutes of Health Research (471606) Article Versions (2) version 2 Revised Published: 21 May 2024, 13:120 https://doi.org/10.12688/f1000research.143514.2 version 1 Published: 19 Feb 2024, 13:120 https://doi.org/10.12688/f1000research.143514.1 Copyright © 2024 Cheng MF et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics Views Downloads F1000Research - - PubMed Central info_outline Data from PMC are received and updated monthly. - - Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article Cheng MF, Abdullah FS and Buechler MB. Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.12688/f1000research.143514.2 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Version 2 VERSION 2 PUBLISHED 21 May 2024 Revised Views 0 Cite How to cite this report: Tallquist MD. Reviewer Report For: Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.5256/f1000research.166451.r280957 ) The direct URL for this report is: https://f1000research.com/articles/13-120/v2#referee-response-280957 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 09 Jul 2024 Michelle D Tallquist , John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, USA Approved VIEWS 0 https://doi.org/10.5256/f1000research.166451.r280957 The authors have ... Continue reading READ ALL The authors have addressed my main concerns. Competing Interests: No competing interests were disclosed. Reviewer Expertise: Fibroblast development, PDGF receptor signaling, fibrosis. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Tallquist MD. Reviewer Report For: Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.5256/f1000research.166451.r280957 ) The direct URL for this report is: https://f1000research.com/articles/13-120/v2#referee-response-280957 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Pikor N. Reviewer Report For: Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.5256/f1000research.166451.r280956 ) The direct URL for this report is: https://f1000research.com/articles/13-120/v2#referee-response-280956 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 12 Jun 2024 Natalia Pikor , Institute of Immunobiology, Kantonsspital Sankt Gallen (Ringgold ID: 30883), St. Gallen, St. Gallen, Switzerland; ETH Zurich, Zürich, Zurich, Switzerland Approved VIEWS 0 https://doi.org/10.5256/f1000research.166451.r280956 The revised version of this manuscript ... Continue reading READ ALL The revised version of this manuscript is improved and approved for indexing. Competing Interests: No competing interests were disclosed. Reviewer Expertise: Fibroblast immunobiology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Pikor N. Reviewer Report For: Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.5256/f1000research.166451.r280956 ) The direct URL for this report is: https://f1000research.com/articles/13-120/v2#referee-response-280956 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Version 1 VERSION 1 PUBLISHED 19 Feb 2024 Views 0 Cite How to cite this report: Tallquist MD. Reviewer Report For: Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.5256/f1000research.157187.r252088 ) The direct URL for this report is: https://f1000research.com/articles/13-120/v1#referee-response-252088 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 23 Mar 2024 Michelle D Tallquist , John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, USA Approved with Reservations VIEWS 0 https://doi.org/10.5256/f1000research.157187.r252088 The review by Cheng et al poses the question whether all fibroblast subsets utilize the same growth factors signaling pathways for survival and proliferation. It then discusses three receptor families known to signal in fibroblasts, TGFbR, FGFR, and PDGFR. The ... Continue reading READ ALL The review by Cheng et al poses the question whether all fibroblast subsets utilize the same growth factors signaling pathways for survival and proliferation. It then discusses three receptor families known to signal in fibroblasts, TGFbR, FGFR, and PDGFR. The review highlights some manuscripts describing the actions of these receptors on a wide range of fibroblast/fibroadipocyte/mesenchymal stem cell populations. Comments While the title suggests a comprehensive review on this topic, the review focuses on three growth factor receptor families, TGF-bR, FGFR, and PDGFR. Because of the limited focus of the review, I would recommend revision of the title which more closely reflects the scope of the review. The review places an emphasis on a dermatopontin expressing fibroblast population (Buechler MB, et al 2021 [Ref 1]). Multiple references focus on mesenchymal stem cells, adipocytes and preadipocytes. The range of fibroblasts discussed is also very broad. It might be helpful to the reader to understand the connection and definition of these different populations of cells. The organ range of fibroblasts discussed is also broad with a mention of prostate, dermis, skeletal muscle, cardiac, pulmonary, kidney, pancreas, and cancer associated fibroblasts. Figure 2 is an oversimplification of the receptor pathways illustrated. The history of the growth factor receptor’s discovery seems a bit out of the scope of the review. Minor comments Reference 50 is not Shook et al. Reference 49 does not describe lack of PDGFRbeta Is the topic of the review discussed comprehensively in the context of the current literature? No Are all factual statements correct and adequately supported by citations? Partly Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes References 1. Buechler MB, Pradhan RN, Krishnamurty AT, Cox C, et al.: Cross-tissue organization of the fibroblast lineage. Nature . 2021; 593 (7860): 575-579 PubMed Abstract | Publisher Full Text Competing Interests: No competing interests were disclosed. Reviewer Expertise: Fibroblast development, PDGF receptor signaling, fibrosis. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Tallquist MD. Reviewer Report For: Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.5256/f1000research.157187.r252088 ) The direct URL for this report is: https://f1000research.com/articles/13-120/v1#referee-response-252088 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Author Response 26 Jun 2024 Maye Cheng , Immunology, University of Toronto, Toronto, M5S 1A8, Canada 26 Jun 2024 Author Response We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's ... Continue reading We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's comments The review by Cheng, et al. poses the question whether all fibroblast subsets utilize the same growth factors signaling pathways for survival and proliferation. It then discusses three receptor families known to signal in fibroblasts, TGFbR, FGFR, and PDGFR. The review highlights some manuscripts describing the actions of these receptors on a wide range of fibroblast/fibroadipocyte/mesenchymal stem cell populations. 1. While the title suggests a comprehensive review on this topic, the review focuses on three growth factor receptor families, TGF-bR, FGFR, and PDGFR. Because of the limited focus of the review, I would recommend revision of the title which more closely reflects the scope of the review. Author Response: We agree with the reviewer’s comment. As suggested, we have revised the title to “ Essential growth factor receptors for fibroblast homeostasis and activation : Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR)” to reflect the emphasis of the review. 2. The review places an emphasis on a dermatopontin expressing fibroblast population ( Buechler MB, et al 2021 [Ref 1] ). Multiple references focus on mesenchymal stem cells, adipocytes and preadipocytes. The range of fibroblasts discussed is also very broad. It might be helpful to the reader to understand the connection and definition of these different populations of cells. Author Response: We thank the reviewer for their insightful comment. As suggested, we have added definitions of these cells and a discussion of the crosstalk between these populations in lines 113-124. 4. The organ range of fibroblasts discussed is also broad with a mention of prostate, dermis, skeletal muscle, cardiac, pulmonary, kidney, pancreas, and cancer associated fibroblasts. Author Response: We acknowledge the reviewer’s observation. We included studies across a variety of tissues to broadly examine the effects of growth factor receptors in the body. 5. Figure 2 is an oversimplification of the receptor pathways illustrated. Author Response: We thank the reviewer for their comment. The reviewer is correct and we have revised the figure to include several additional adaptor molecules and significant pathways. 6. The history of the growth factor receptor’s discovery seems a bit out of the scope of the review. Author Response: We thank the reviewer for pointing this out. We have removed some portions of the review discussing the history of each receptor. Minor comments Reference 50 is not Shook et al. Author Response: We thank the reviewer for highlighting this. We have inserted the correct reference (62). Reference 49 does not describe lack of PDGFRbeta Author Response: We thank the reviewer for highlighting this. We have inserted the correct reference (56). We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's comments The review by Cheng, et al. poses the question whether all fibroblast subsets utilize the same growth factors signaling pathways for survival and proliferation. It then discusses three receptor families known to signal in fibroblasts, TGFbR, FGFR, and PDGFR. The review highlights some manuscripts describing the actions of these receptors on a wide range of fibroblast/fibroadipocyte/mesenchymal stem cell populations. 1. While the title suggests a comprehensive review on this topic, the review focuses on three growth factor receptor families, TGF-bR, FGFR, and PDGFR. Because of the limited focus of the review, I would recommend revision of the title which more closely reflects the scope of the review. Author Response: We agree with the reviewer’s comment. As suggested, we have revised the title to “ Essential growth factor receptors for fibroblast homeostasis and activation : Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR)” to reflect the emphasis of the review. 2. The review places an emphasis on a dermatopontin expressing fibroblast population ( Buechler MB, et al 2021 [Ref 1] ). Multiple references focus on mesenchymal stem cells, adipocytes and preadipocytes. The range of fibroblasts discussed is also very broad. It might be helpful to the reader to understand the connection and definition of these different populations of cells. Author Response: We thank the reviewer for their insightful comment. As suggested, we have added definitions of these cells and a discussion of the crosstalk between these populations in lines 113-124. 4. The organ range of fibroblasts discussed is also broad with a mention of prostate, dermis, skeletal muscle, cardiac, pulmonary, kidney, pancreas, and cancer associated fibroblasts. Author Response: We acknowledge the reviewer’s observation. We included studies across a variety of tissues to broadly examine the effects of growth factor receptors in the body. 5. Figure 2 is an oversimplification of the receptor pathways illustrated. Author Response: We thank the reviewer for their comment. The reviewer is correct and we have revised the figure to include several additional adaptor molecules and significant pathways. 6. The history of the growth factor receptor’s discovery seems a bit out of the scope of the review. Author Response: We thank the reviewer for pointing this out. We have removed some portions of the review discussing the history of each receptor. Minor comments Reference 50 is not Shook et al. Author Response: We thank the reviewer for highlighting this. We have inserted the correct reference (62). Reference 49 does not describe lack of PDGFRbeta Author Response: We thank the reviewer for highlighting this. We have inserted the correct reference (56). Competing Interests: No competing interests were disclosed. Close Report a concern Respond or Comment COMMENTS ON THIS REPORT Author Response 26 Jun 2024 Maye Cheng , Immunology, University of Toronto, Toronto, M5S 1A8, Canada 26 Jun 2024 Author Response We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's ... Continue reading We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's comments The review by Cheng, et al. poses the question whether all fibroblast subsets utilize the same growth factors signaling pathways for survival and proliferation. It then discusses three receptor families known to signal in fibroblasts, TGFbR, FGFR, and PDGFR. The review highlights some manuscripts describing the actions of these receptors on a wide range of fibroblast/fibroadipocyte/mesenchymal stem cell populations. 1. While the title suggests a comprehensive review on this topic, the review focuses on three growth factor receptor families, TGF-bR, FGFR, and PDGFR. Because of the limited focus of the review, I would recommend revision of the title which more closely reflects the scope of the review. Author Response: We agree with the reviewer’s comment. As suggested, we have revised the title to “ Essential growth factor receptors for fibroblast homeostasis and activation : Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR)” to reflect the emphasis of the review. 2. The review places an emphasis on a dermatopontin expressing fibroblast population ( Buechler MB, et al 2021 [Ref 1] ). Multiple references focus on mesenchymal stem cells, adipocytes and preadipocytes. The range of fibroblasts discussed is also very broad. It might be helpful to the reader to understand the connection and definition of these different populations of cells. Author Response: We thank the reviewer for their insightful comment. As suggested, we have added definitions of these cells and a discussion of the crosstalk between these populations in lines 113-124. 4. The organ range of fibroblasts discussed is also broad with a mention of prostate, dermis, skeletal muscle, cardiac, pulmonary, kidney, pancreas, and cancer associated fibroblasts. Author Response: We acknowledge the reviewer’s observation. We included studies across a variety of tissues to broadly examine the effects of growth factor receptors in the body. 5. Figure 2 is an oversimplification of the receptor pathways illustrated. Author Response: We thank the reviewer for their comment. The reviewer is correct and we have revised the figure to include several additional adaptor molecules and significant pathways. 6. The history of the growth factor receptor’s discovery seems a bit out of the scope of the review. Author Response: We thank the reviewer for pointing this out. We have removed some portions of the review discussing the history of each receptor. Minor comments Reference 50 is not Shook et al. Author Response: We thank the reviewer for highlighting this. We have inserted the correct reference (62). Reference 49 does not describe lack of PDGFRbeta Author Response: We thank the reviewer for highlighting this. We have inserted the correct reference (56). We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's comments The review by Cheng, et al. poses the question whether all fibroblast subsets utilize the same growth factors signaling pathways for survival and proliferation. It then discusses three receptor families known to signal in fibroblasts, TGFbR, FGFR, and PDGFR. The review highlights some manuscripts describing the actions of these receptors on a wide range of fibroblast/fibroadipocyte/mesenchymal stem cell populations. 1. While the title suggests a comprehensive review on this topic, the review focuses on three growth factor receptor families, TGF-bR, FGFR, and PDGFR. Because of the limited focus of the review, I would recommend revision of the title which more closely reflects the scope of the review. Author Response: We agree with the reviewer’s comment. As suggested, we have revised the title to “ Essential growth factor receptors for fibroblast homeostasis and activation : Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR)” to reflect the emphasis of the review. 2. The review places an emphasis on a dermatopontin expressing fibroblast population ( Buechler MB, et al 2021 [Ref 1] ). Multiple references focus on mesenchymal stem cells, adipocytes and preadipocytes. The range of fibroblasts discussed is also very broad. It might be helpful to the reader to understand the connection and definition of these different populations of cells. Author Response: We thank the reviewer for their insightful comment. As suggested, we have added definitions of these cells and a discussion of the crosstalk between these populations in lines 113-124. 4. The organ range of fibroblasts discussed is also broad with a mention of prostate, dermis, skeletal muscle, cardiac, pulmonary, kidney, pancreas, and cancer associated fibroblasts. Author Response: We acknowledge the reviewer’s observation. We included studies across a variety of tissues to broadly examine the effects of growth factor receptors in the body. 5. Figure 2 is an oversimplification of the receptor pathways illustrated. Author Response: We thank the reviewer for their comment. The reviewer is correct and we have revised the figure to include several additional adaptor molecules and significant pathways. 6. The history of the growth factor receptor’s discovery seems a bit out of the scope of the review. Author Response: We thank the reviewer for pointing this out. We have removed some portions of the review discussing the history of each receptor. Minor comments Reference 50 is not Shook et al. Author Response: We thank the reviewer for highlighting this. We have inserted the correct reference (62). Reference 49 does not describe lack of PDGFRbeta Author Response: We thank the reviewer for highlighting this. We have inserted the correct reference (56). Competing Interests: No competing interests were disclosed. Close Report a concern COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Pikor N. Reviewer Report For: Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.5256/f1000research.157187.r252079 ) The direct URL for this report is: https://f1000research.com/articles/13-120/v1#referee-response-252079 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 20 Mar 2024 Natalia Pikor , Institute of Immunobiology, Kantonsspital Sankt Gallen (Ringgold ID: 30883), St. Gallen, St. Gallen, Switzerland; ETH Zurich, Zürich, Zurich, Switzerland Approved with Reservations VIEWS 0 https://doi.org/10.5256/f1000research.157187.r252079 In this article, Buechler and colleagues review the literature concerning the influence of key growth factors and cytokines on fibroblast sustenance and activation. In light of the author's seminal contribution to defining Dpt+ universal fibroblasts, an emphasis is placed on ... Continue reading READ ALL In this article, Buechler and colleagues review the literature concerning the influence of key growth factors and cytokines on fibroblast sustenance and activation. In light of the author's seminal contribution to defining Dpt+ universal fibroblasts, an emphasis is placed on the potential relevance of each factor on progenitor fibroblasts. The authors have chosen to focus on fibroblast growth factors, platelet-derived growth factors and TGF-beta, in their role for fibroblast homeostasis, maintenance/proliferation and myofibroblastic activation/differentiation. In the introduction an emphasis is placed on universal fibroblasts being a potential progenitor population that can on one hand maintain stemless, and on the other, give rise to both inflammatory fibroblasts and contractile myofibroblasts. Notably, a discussion of the activation factors mediating the differentiation of inflammatory fibroblasts is strikingly missing, despite the wealth of knowledge of tumor necrosis factor superfamily members capable of giving rise to the prototypical inflammatory fibroblast - the fibroblastic reticular cell. Of note, recent studies highlight the presence of the universal progenitor fibroblast population within human and murine lymphoid organs [De Martin A, et.al. 2023 (ref 1), Lütge M, et.al. 2023 (Ref 2)], and several lineage-tracing studies have elucidated the perivascular origin of lymphoid organ FRCs [Cheng HW, et. al. 2019 (ref 3), Prados A, et. al. 2021 (Ref 4)], which is compatible with the paradigm of universal fibroblasts. This section would be a welcome addition to this otherwise comprehensive overview of cues governing fibroblast sustenance and activation. As a minor comment on the referenced literature - in its current form the review references 26 other reviews (42% of the references). To better guide a keen reader to the relevant literature, it may be favourable to replace some of the reviews with the main primary papers. Is the topic of the review discussed comprehensively in the context of the current literature? Yes Are all factual statements correct and adequately supported by citations? Partly Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes References 1. De Martin A, Stanossek Y, Lütge M, Cadosch N, et al.: PI16+ reticular cells in human palatine tonsils govern T cell activity in distinct subepithelial niches. Nat Immunol . 2023; 24 (7): 1138-1148 PubMed Abstract | Publisher Full Text 2. Lütge M, De Martin A, Gil-Cruz C, Perez-Shibayama C, et al.: Conserved stromal-immune cell circuits secure B cell homeostasis and function. Nat Immunol . 2023; 24 (7): 1149-1160 PubMed Abstract | Publisher Full Text 3. Cheng HW, Onder L, Novkovic M, Soneson C, et al.: Origin and differentiation trajectories of fibroblastic reticular cells in the splenic white pulp. Nat Commun . 2019; 10 (1): 1739 PubMed Abstract | Publisher Full Text 4. Prados A, Onder L, Cheng HW, Mörbe U, et al.: Fibroblastic reticular cell lineage convergence in Peyer's patches governs intestinal immunity. Nat Immunol . 2021; 22 (4): 510-519 PubMed Abstract | Publisher Full Text Competing Interests: No competing interests were disclosed. Reviewer Expertise: Fibroblast immunobiology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Pikor N. Reviewer Report For: Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.5256/f1000research.157187.r252079 ) The direct URL for this report is: https://f1000research.com/articles/13-120/v1#referee-response-252079 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Author Response 24 Jun 2024 Maye Cheng , Immunology, University of Toronto, Toronto, M5S 1A8, Canada 24 Jun 2024 Author Response We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's ... Continue reading We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's comments In this article, Buechler and colleagues review the literature concerning the influence of key growth factors and cytokines on fibroblast sustenance and activation. In light of the author's seminal contribution to defining Dpt+ universal fibroblasts, an emphasis is placed on the potential relevance of each factor on progenitor fibroblasts. The authors have chosen to focus on fibroblast growth factors, platelet-derived growth factors and TGF-beta, in their role for fibroblast homeostasis, maintenance/proliferation and myofibroblastic activation/differentiation. In the introduction an emphasis is placed on universal fibroblasts being a potential progenitor population that can on one hand maintain stemless, and on the other, give rise to both inflammatory fibroblasts and contractile myofibroblasts. 1. Notably, a discussion of the activation factors mediating the differentiation of inflammatory fibroblasts is strikingly missing, despite the wealth of knowledge of tumor necrosis factor superfamily members capable of giving rise to the prototypical inflammatory fibroblast - the fibroblastic reticular cell. We thank the reviewer for mentioning this important comment. We have referenced the importance of TNFSF members in promoting activation of inflammatory fibroblasts in lines 489-492. We feel that the contribution of TNFSF members is out of the scope of this review as we focused here on FGFR, PDGFR, and TGFβR. Additionally, TNFSF members and their association with fibroblasts have been recently reviewed in Steele et al. (2023). 2. Of note, recent studies highlight the presence of the universal progenitor fibroblast population within human and murine lymphoid organs [De Martin A, et.al. 2023 (ref 1), Lütge M, et.al. 2023 (Ref 2)], and several lineage-tracing studies have elucidated the perivascular origin of lymphoid organ FRCs [Cheng HW, et. al. 2019 (ref 3), Prados A, et. al. 2021 (Ref 4)], which is compatible with the paradigm of universal fibroblasts. This section would be a welcome addition to this otherwise comprehensive overview of cues governing fibroblast sustenance and activation. We appreciate the reviewer’s comments. We have included remarks (lines 125-130) on the recent studies examining Pi16+ fibroblasts in SLOs as an additional rationale for examining the growth factor requirements for Dpt+ fibroblasts. We have also reviewed and included a section on the origin of FRCs in SLOs in lines 105-112. 3. As a minor comment on the referenced literature - in its current form the review references 26 other reviews (42% of the references). To better guide a keen reader to the relevant literature, it may be favourable to replace some of the reviews with the main primary papers. We agree with the reviewer’s insight. We have added additional references from primary sources. Currently, this submission contains 32% of references from other reviews. We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's comments In this article, Buechler and colleagues review the literature concerning the influence of key growth factors and cytokines on fibroblast sustenance and activation. In light of the author's seminal contribution to defining Dpt+ universal fibroblasts, an emphasis is placed on the potential relevance of each factor on progenitor fibroblasts. The authors have chosen to focus on fibroblast growth factors, platelet-derived growth factors and TGF-beta, in their role for fibroblast homeostasis, maintenance/proliferation and myofibroblastic activation/differentiation. In the introduction an emphasis is placed on universal fibroblasts being a potential progenitor population that can on one hand maintain stemless, and on the other, give rise to both inflammatory fibroblasts and contractile myofibroblasts. 1. Notably, a discussion of the activation factors mediating the differentiation of inflammatory fibroblasts is strikingly missing, despite the wealth of knowledge of tumor necrosis factor superfamily members capable of giving rise to the prototypical inflammatory fibroblast - the fibroblastic reticular cell. We thank the reviewer for mentioning this important comment. We have referenced the importance of TNFSF members in promoting activation of inflammatory fibroblasts in lines 489-492. We feel that the contribution of TNFSF members is out of the scope of this review as we focused here on FGFR, PDGFR, and TGFβR. Additionally, TNFSF members and their association with fibroblasts have been recently reviewed in Steele et al. (2023). 2. Of note, recent studies highlight the presence of the universal progenitor fibroblast population within human and murine lymphoid organs [De Martin A, et.al. 2023 (ref 1), Lütge M, et.al. 2023 (Ref 2)], and several lineage-tracing studies have elucidated the perivascular origin of lymphoid organ FRCs [Cheng HW, et. al. 2019 (ref 3), Prados A, et. al. 2021 (Ref 4)], which is compatible with the paradigm of universal fibroblasts. This section would be a welcome addition to this otherwise comprehensive overview of cues governing fibroblast sustenance and activation. We appreciate the reviewer’s comments. We have included remarks (lines 125-130) on the recent studies examining Pi16+ fibroblasts in SLOs as an additional rationale for examining the growth factor requirements for Dpt+ fibroblasts. We have also reviewed and included a section on the origin of FRCs in SLOs in lines 105-112. 3. As a minor comment on the referenced literature - in its current form the review references 26 other reviews (42% of the references). To better guide a keen reader to the relevant literature, it may be favourable to replace some of the reviews with the main primary papers. We agree with the reviewer’s insight. We have added additional references from primary sources. Currently, this submission contains 32% of references from other reviews. Competing Interests: No competing interests were disclosed. Close Report a concern Respond or Comment COMMENTS ON THIS REPORT Author Response 24 Jun 2024 Maye Cheng , Immunology, University of Toronto, Toronto, M5S 1A8, Canada 24 Jun 2024 Author Response We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's ... Continue reading We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's comments In this article, Buechler and colleagues review the literature concerning the influence of key growth factors and cytokines on fibroblast sustenance and activation. In light of the author's seminal contribution to defining Dpt+ universal fibroblasts, an emphasis is placed on the potential relevance of each factor on progenitor fibroblasts. The authors have chosen to focus on fibroblast growth factors, platelet-derived growth factors and TGF-beta, in their role for fibroblast homeostasis, maintenance/proliferation and myofibroblastic activation/differentiation. In the introduction an emphasis is placed on universal fibroblasts being a potential progenitor population that can on one hand maintain stemless, and on the other, give rise to both inflammatory fibroblasts and contractile myofibroblasts. 1. Notably, a discussion of the activation factors mediating the differentiation of inflammatory fibroblasts is strikingly missing, despite the wealth of knowledge of tumor necrosis factor superfamily members capable of giving rise to the prototypical inflammatory fibroblast - the fibroblastic reticular cell. We thank the reviewer for mentioning this important comment. We have referenced the importance of TNFSF members in promoting activation of inflammatory fibroblasts in lines 489-492. We feel that the contribution of TNFSF members is out of the scope of this review as we focused here on FGFR, PDGFR, and TGFβR. Additionally, TNFSF members and their association with fibroblasts have been recently reviewed in Steele et al. (2023). 2. Of note, recent studies highlight the presence of the universal progenitor fibroblast population within human and murine lymphoid organs [De Martin A, et.al. 2023 (ref 1), Lütge M, et.al. 2023 (Ref 2)], and several lineage-tracing studies have elucidated the perivascular origin of lymphoid organ FRCs [Cheng HW, et. al. 2019 (ref 3), Prados A, et. al. 2021 (Ref 4)], which is compatible with the paradigm of universal fibroblasts. This section would be a welcome addition to this otherwise comprehensive overview of cues governing fibroblast sustenance and activation. We appreciate the reviewer’s comments. We have included remarks (lines 125-130) on the recent studies examining Pi16+ fibroblasts in SLOs as an additional rationale for examining the growth factor requirements for Dpt+ fibroblasts. We have also reviewed and included a section on the origin of FRCs in SLOs in lines 105-112. 3. As a minor comment on the referenced literature - in its current form the review references 26 other reviews (42% of the references). To better guide a keen reader to the relevant literature, it may be favourable to replace some of the reviews with the main primary papers. We agree with the reviewer’s insight. We have added additional references from primary sources. Currently, this submission contains 32% of references from other reviews. We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's comments In this article, Buechler and colleagues review the literature concerning the influence of key growth factors and cytokines on fibroblast sustenance and activation. In light of the author's seminal contribution to defining Dpt+ universal fibroblasts, an emphasis is placed on the potential relevance of each factor on progenitor fibroblasts. The authors have chosen to focus on fibroblast growth factors, platelet-derived growth factors and TGF-beta, in their role for fibroblast homeostasis, maintenance/proliferation and myofibroblastic activation/differentiation. In the introduction an emphasis is placed on universal fibroblasts being a potential progenitor population that can on one hand maintain stemless, and on the other, give rise to both inflammatory fibroblasts and contractile myofibroblasts. 1. Notably, a discussion of the activation factors mediating the differentiation of inflammatory fibroblasts is strikingly missing, despite the wealth of knowledge of tumor necrosis factor superfamily members capable of giving rise to the prototypical inflammatory fibroblast - the fibroblastic reticular cell. We thank the reviewer for mentioning this important comment. We have referenced the importance of TNFSF members in promoting activation of inflammatory fibroblasts in lines 489-492. We feel that the contribution of TNFSF members is out of the scope of this review as we focused here on FGFR, PDGFR, and TGFβR. Additionally, TNFSF members and their association with fibroblasts have been recently reviewed in Steele et al. (2023). 2. Of note, recent studies highlight the presence of the universal progenitor fibroblast population within human and murine lymphoid organs [De Martin A, et.al. 2023 (ref 1), Lütge M, et.al. 2023 (Ref 2)], and several lineage-tracing studies have elucidated the perivascular origin of lymphoid organ FRCs [Cheng HW, et. al. 2019 (ref 3), Prados A, et. al. 2021 (Ref 4)], which is compatible with the paradigm of universal fibroblasts. This section would be a welcome addition to this otherwise comprehensive overview of cues governing fibroblast sustenance and activation. We appreciate the reviewer’s comments. We have included remarks (lines 125-130) on the recent studies examining Pi16+ fibroblasts in SLOs as an additional rationale for examining the growth factor requirements for Dpt+ fibroblasts. We have also reviewed and included a section on the origin of FRCs in SLOs in lines 105-112. 3. As a minor comment on the referenced literature - in its current form the review references 26 other reviews (42% of the references). To better guide a keen reader to the relevant literature, it may be favourable to replace some of the reviews with the main primary papers. We agree with the reviewer’s insight. We have added additional references from primary sources. Currently, this submission contains 32% of references from other reviews. Competing Interests: No competing interests were disclosed. Close Report a concern COMMENT ON THIS REPORT Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 19 Feb 2024 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Reviewer Reports Invited Reviewers 1 2 Version 2 (revision) 21 May 24 read read Version 1 19 Feb 24 read read Natalia Pikor , Kantonsspital Sankt Gallen (Ringgold ID: 30883), St. Gallen, Switzerland; ETH Zurich, Zürich, Switzerland Michelle D Tallquist , University of Hawaii at Manoa, Honolulu, USA Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert Browse by related subjects keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Tallquist M. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 09 Jul 2024 | for Version 2 Michelle D Tallquist , John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, USA 0 Views copyright © 2024 Tallquist M. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The authors have addressed my main concerns. Competing Interests No competing interests were disclosed. Reviewer Expertise Fibroblast development, PDGF receptor signaling, fibrosis. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Tallquist MD. Peer Review Report For: Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.5256/f1000research.166451.r280957) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-120/v2#referee-response-280957 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Pikor N. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 12 Jun 2024 | for Version 2 Natalia Pikor , Institute of Immunobiology, Kantonsspital Sankt Gallen (Ringgold ID: 30883), St. Gallen, St. Gallen, Switzerland; ETH Zurich, Zürich, Zurich, Switzerland 0 Views copyright © 2024 Pikor N. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The revised version of this manuscript is improved and approved for indexing. Competing Interests No competing interests were disclosed. Reviewer Expertise Fibroblast immunobiology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Pikor N. Peer Review Report For: Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.5256/f1000research.166451.r280956) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-120/v2#referee-response-280956 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Tallquist M. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 23 Mar 2024 | for Version 1 Michelle D Tallquist , John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, USA 0 Views copyright © 2024 Tallquist M. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (1) Approved With Reservations info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The review by Cheng et al poses the question whether all fibroblast subsets utilize the same growth factors signaling pathways for survival and proliferation. It then discusses three receptor families known to signal in fibroblasts, TGFbR, FGFR, and PDGFR. The review highlights some manuscripts describing the actions of these receptors on a wide range of fibroblast/fibroadipocyte/mesenchymal stem cell populations. Comments While the title suggests a comprehensive review on this topic, the review focuses on three growth factor receptor families, TGF-bR, FGFR, and PDGFR. Because of the limited focus of the review, I would recommend revision of the title which more closely reflects the scope of the review. The review places an emphasis on a dermatopontin expressing fibroblast population (Buechler MB, et al 2021 [Ref 1]). Multiple references focus on mesenchymal stem cells, adipocytes and preadipocytes. The range of fibroblasts discussed is also very broad. It might be helpful to the reader to understand the connection and definition of these different populations of cells. The organ range of fibroblasts discussed is also broad with a mention of prostate, dermis, skeletal muscle, cardiac, pulmonary, kidney, pancreas, and cancer associated fibroblasts. Figure 2 is an oversimplification of the receptor pathways illustrated. The history of the growth factor receptor’s discovery seems a bit out of the scope of the review. Minor comments Reference 50 is not Shook et al. Reference 49 does not describe lack of PDGFRbeta Is the topic of the review discussed comprehensively in the context of the current literature? No Are all factual statements correct and adequately supported by citations? Partly Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes References 1. Buechler MB, Pradhan RN, Krishnamurty AT, Cox C, et al.: Cross-tissue organization of the fibroblast lineage. Nature . 2021; 593 (7860): 575-579 PubMed Abstract | Publisher Full Text Competing Interests No competing interests were disclosed. Reviewer Expertise Fibroblast development, PDGF receptor signaling, fibrosis. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. reply Respond to this report Responses (1) Author Response 26 Jun 2024 Maye Cheng, Immunology, University of Toronto, Toronto, M5S 1A8, Canada We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's comments The review by Cheng, et al. poses the question whether all fibroblast subsets utilize the same growth factors signaling pathways for survival and proliferation. It then discusses three receptor families known to signal in fibroblasts, TGFbR, FGFR, and PDGFR. The review highlights some manuscripts describing the actions of these receptors on a wide range of fibroblast/fibroadipocyte/mesenchymal stem cell populations. 1. While the title suggests a comprehensive review on this topic, the review focuses on three growth factor receptor families, TGF-bR, FGFR, and PDGFR. Because of the limited focus of the review, I would recommend revision of the title which more closely reflects the scope of the review. Author Response: We agree with the reviewer’s comment. As suggested, we have revised the title to “ Essential growth factor receptors for fibroblast homeostasis and activation : Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR)” to reflect the emphasis of the review. 2. The review places an emphasis on a dermatopontin expressing fibroblast population ( Buechler MB, et al 2021 [Ref 1] ). Multiple references focus on mesenchymal stem cells, adipocytes and preadipocytes. The range of fibroblasts discussed is also very broad. It might be helpful to the reader to understand the connection and definition of these different populations of cells. Author Response: We thank the reviewer for their insightful comment. As suggested, we have added definitions of these cells and a discussion of the crosstalk between these populations in lines 113-124. 4. The organ range of fibroblasts discussed is also broad with a mention of prostate, dermis, skeletal muscle, cardiac, pulmonary, kidney, pancreas, and cancer associated fibroblasts. Author Response: We acknowledge the reviewer’s observation. We included studies across a variety of tissues to broadly examine the effects of growth factor receptors in the body. 5. Figure 2 is an oversimplification of the receptor pathways illustrated. Author Response: We thank the reviewer for their comment. The reviewer is correct and we have revised the figure to include several additional adaptor molecules and significant pathways. 6. The history of the growth factor receptor’s discovery seems a bit out of the scope of the review. Author Response: We thank the reviewer for pointing this out. We have removed some portions of the review discussing the history of each receptor. Minor comments Reference 50 is not Shook et al. Author Response: We thank the reviewer for highlighting this. We have inserted the correct reference (62). Reference 49 does not describe lack of PDGFRbeta Author Response: We thank the reviewer for highlighting this. We have inserted the correct reference (56). View more View less Competing Interests No competing interests were disclosed. reply Respond Report a concern Tallquist MD. Peer Review Report For: Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.5256/f1000research.157187.r252088) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-120/v1#referee-response-252088 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Pikor N. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 20 Mar 2024 | for Version 1 Natalia Pikor , Institute of Immunobiology, Kantonsspital Sankt Gallen (Ringgold ID: 30883), St. Gallen, St. Gallen, Switzerland; ETH Zurich, Zürich, Zurich, Switzerland 0 Views copyright © 2024 Pikor N. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (1) Approved With Reservations info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions In this article, Buechler and colleagues review the literature concerning the influence of key growth factors and cytokines on fibroblast sustenance and activation. In light of the author's seminal contribution to defining Dpt+ universal fibroblasts, an emphasis is placed on the potential relevance of each factor on progenitor fibroblasts. The authors have chosen to focus on fibroblast growth factors, platelet-derived growth factors and TGF-beta, in their role for fibroblast homeostasis, maintenance/proliferation and myofibroblastic activation/differentiation. In the introduction an emphasis is placed on universal fibroblasts being a potential progenitor population that can on one hand maintain stemless, and on the other, give rise to both inflammatory fibroblasts and contractile myofibroblasts. Notably, a discussion of the activation factors mediating the differentiation of inflammatory fibroblasts is strikingly missing, despite the wealth of knowledge of tumor necrosis factor superfamily members capable of giving rise to the prototypical inflammatory fibroblast - the fibroblastic reticular cell. Of note, recent studies highlight the presence of the universal progenitor fibroblast population within human and murine lymphoid organs [De Martin A, et.al. 2023 (ref 1), Lütge M, et.al. 2023 (Ref 2)], and several lineage-tracing studies have elucidated the perivascular origin of lymphoid organ FRCs [Cheng HW, et. al. 2019 (ref 3), Prados A, et. al. 2021 (Ref 4)], which is compatible with the paradigm of universal fibroblasts. This section would be a welcome addition to this otherwise comprehensive overview of cues governing fibroblast sustenance and activation. As a minor comment on the referenced literature - in its current form the review references 26 other reviews (42% of the references). To better guide a keen reader to the relevant literature, it may be favourable to replace some of the reviews with the main primary papers. Is the topic of the review discussed comprehensively in the context of the current literature? Yes Are all factual statements correct and adequately supported by citations? Partly Is the review written in accessible language? Yes Are the conclusions drawn appropriate in the context of the current research literature? Yes References 1. De Martin A, Stanossek Y, Lütge M, Cadosch N, et al.: PI16+ reticular cells in human palatine tonsils govern T cell activity in distinct subepithelial niches. Nat Immunol . 2023; 24 (7): 1138-1148 PubMed Abstract | Publisher Full Text 2. Lütge M, De Martin A, Gil-Cruz C, Perez-Shibayama C, et al.: Conserved stromal-immune cell circuits secure B cell homeostasis and function. Nat Immunol . 2023; 24 (7): 1149-1160 PubMed Abstract | Publisher Full Text 3. Cheng HW, Onder L, Novkovic M, Soneson C, et al.: Origin and differentiation trajectories of fibroblastic reticular cells in the splenic white pulp. Nat Commun . 2019; 10 (1): 1739 PubMed Abstract | Publisher Full Text 4. Prados A, Onder L, Cheng HW, Mörbe U, et al.: Fibroblastic reticular cell lineage convergence in Peyer's patches governs intestinal immunity. Nat Immunol . 2021; 22 (4): 510-519 PubMed Abstract | Publisher Full Text Competing Interests No competing interests were disclosed. Reviewer Expertise Fibroblast immunobiology I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. reply Respond to this report Responses (1) Author Response 24 Jun 2024 Maye Cheng, Immunology, University of Toronto, Toronto, M5S 1A8, Canada We thank both reviewers for dedicating time to provide in-depth and constructive comments for this submission. Their feedback and insight have significantly improved the quality of this review. Reviewer's comments In this article, Buechler and colleagues review the literature concerning the influence of key growth factors and cytokines on fibroblast sustenance and activation. In light of the author's seminal contribution to defining Dpt+ universal fibroblasts, an emphasis is placed on the potential relevance of each factor on progenitor fibroblasts. The authors have chosen to focus on fibroblast growth factors, platelet-derived growth factors and TGF-beta, in their role for fibroblast homeostasis, maintenance/proliferation and myofibroblastic activation/differentiation. In the introduction an emphasis is placed on universal fibroblasts being a potential progenitor population that can on one hand maintain stemless, and on the other, give rise to both inflammatory fibroblasts and contractile myofibroblasts. 1. Notably, a discussion of the activation factors mediating the differentiation of inflammatory fibroblasts is strikingly missing, despite the wealth of knowledge of tumor necrosis factor superfamily members capable of giving rise to the prototypical inflammatory fibroblast - the fibroblastic reticular cell. We thank the reviewer for mentioning this important comment. We have referenced the importance of TNFSF members in promoting activation of inflammatory fibroblasts in lines 489-492. We feel that the contribution of TNFSF members is out of the scope of this review as we focused here on FGFR, PDGFR, and TGFβR. Additionally, TNFSF members and their association with fibroblasts have been recently reviewed in Steele et al. (2023). 2. Of note, recent studies highlight the presence of the universal progenitor fibroblast population within human and murine lymphoid organs [De Martin A, et.al. 2023 (ref 1), Lütge M, et.al. 2023 (Ref 2)], and several lineage-tracing studies have elucidated the perivascular origin of lymphoid organ FRCs [Cheng HW, et. al. 2019 (ref 3), Prados A, et. al. 2021 (Ref 4)], which is compatible with the paradigm of universal fibroblasts. This section would be a welcome addition to this otherwise comprehensive overview of cues governing fibroblast sustenance and activation. We appreciate the reviewer’s comments. We have included remarks (lines 125-130) on the recent studies examining Pi16+ fibroblasts in SLOs as an additional rationale for examining the growth factor requirements for Dpt+ fibroblasts. We have also reviewed and included a section on the origin of FRCs in SLOs in lines 105-112. 3. As a minor comment on the referenced literature - in its current form the review references 26 other reviews (42% of the references). To better guide a keen reader to the relevant literature, it may be favourable to replace some of the reviews with the main primary papers. We agree with the reviewer’s insight. We have added additional references from primary sources. Currently, this submission contains 32% of references from other reviews. View more View less Competing Interests No competing interests were disclosed. reply Respond Report a concern Pikor N. Peer Review Report For: Essential growth factor receptors for fibroblast homeostasis and activation: Fibroblast Growth Factor Receptor (FGFR), Platelet Derived Growth Factor Receptor (PDGFR), and Transforming Growth Factor β Receptor (TGFβR) [version 2; peer review: 2 approved] . F1000Research 2024, 13 :120 ( https://doi.org/10.5256/f1000research.157187.r252079) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://f1000research.com/articles/13-120/v1#referee-response-252079 Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with F1000Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = \"Essential growth factor receptors for fibroblast...\".replace(\"'\", ''); var linkedInUrl = \"http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/13-120/v2\" + \"&title=\" + encodeURIComponent(lTitle) + \"&summary=\" + encodeURIComponent('Read the article by '); var deliciousUrl = \"https://del.icio.us/post?url=https://f1000research.com/articles/13-120/v2&title=\" + encodeURIComponent(lTitle); var redditUrl = \"http://reddit.com/submit?url=https://f1000research.com/articles/13-120/v2\" + \"&title=\" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('Cheng MF et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : \"facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com\", services_expanded : \"facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com\", services_custom : [ { name: \"LinkedIn\", url: linkedInUrl, icon:\"/img/icon/at_linkedin.svg\" }, { name: \"Mendeley\", url: \"http://www.mendeley.com/import/?url=https://f1000research.com/articles/13-120/v2/mendeley\", icon:\"/img/icon/at_mendeley.svg\" }, { name: \"Reddit\", url: redditUrl, icon:\"/img/icon/at_reddit.svg\" }, ] }; var addthis_share = { url: \"https://f1000research.com/articles/13-120\", templates : { twitter : \"Essential growth factor receptors for fibroblast homeostasis.... Cheng MF et al., published by \" + \"@F1000Research\" + \", https://f1000research.com/articles/13-120/v2\" } }; if (typeof(addthis) != \"undefined\"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(\".f1r-shares-twitter\").attr(\"href\", \"https://twitter.com/intent/tweet?text=\" + addthis_share.templates.twitter); $(\".f1r-shares-facebook\").attr(\"href\", \"https://www.facebook.com/sharer/sharer.php?u=\" + addthis_share.url); $(\".f1r-shares-linkedin\").attr(\"href\", addthis_config.services_custom[0].url); $(\".f1r-shares-reddit\").attr(\"href\", addthis_config.services_custom[2].url); $(\".f1r-shares-mendelay\").attr(\"href\", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(\".addthis_button_expanded\").each(function(){ var count = $(this).text(); if (count !== \"\" && count != \"0\") $(this).removeClass(\"is-hidden\"); else $(this).addClass(\"is-hidden\"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get(\"/articles/acj/143514/166451\") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay(\"articles\", \"article\", \"166451\"); $(document).ready(function() { $( \"#frame1\" ).on('load', function() { var mydiv = $(this).contents().find(\"div\"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(\".interactive-living-figure-label .icon-more-info\"), titleLivingFigure = tooltipLivingFigure.attr(\"title\"); tooltipLivingFigure.simpletip({ fixed: true, position: [\"-115\", \"30\"], baseClass: 'small-tooltip', content:titleLivingFigure + \" \" }); tooltipLivingFigure.removeAttr(\"title\"); $(\"body\").on(\"click\", \".cite-living-figure\", function(e) { e.preventDefault(); var ref = $(this).attr(\"data-ref\"); $(this).closest(\".living-figure-list-container\").find(\"#\" + ref).fadeIn(200); }); $(\"body\").on(\"click\", \".close-cite-living-figure\", function(e) { e.preventDefault(); $(this).closest(\".popup-window-wrapper\").fadeOut(200); }); $(document).on(\"mouseup\", function(e) { var metricsContainer = $(\".article-metrics-popover-wrapper\"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(\".article-metrics-close-button\").click(); } }); var articleId = $('#articleId').val(); if($(\"#main-article-count-box\").attachArticleMetrics) { $(\"#main-article-count-box\").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(\".new_figshare_widget\"); if (figshareWidget.length > 0) { window.figshare.load(\"f1000\", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr(\"figshare_articleId\") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { \"252083\": 0, \"252082\": 0, \"252081\": 0, \"252080\": 0, \"252087\": 0, \"252086\": 0, \"252085\": 0, \"252084\": 0, \"280956\": 5, \"280957\": 3, \"252088\": 23, \"252079\": 26, }; $(\".referee-response-container,.js-referee-report\").each(function(index, el) { var reportId = $(el).attr(\"data-reportid\"), reportCount = reportIds[reportId] || 0; $(el).find(\".comments-count-container,.js-referee-report-views\").html(reportCount); }); var uuidInput = $(\"#article_uuid\"), oldUUId = uuidInput.val(), newUUId = \"efb9f291-e856-4c8f-8e29-5433414c2304\"; uuidInput.val(newUUId); $(\"a[href*='article_uuid=']\").each(function(index, el) { var newHref = $(el).attr(\"href\").replace(oldUUId, newUUId); $(el).attr(\"href\", newHref); }); }); An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing. Browse Gateways Collections How it Works Contact For Developers Cookie Notice Privacy Notice RSS Submit Your Research Follow us © 2012-2026 F1000 Research Ltd. ISSN 2046-1402 | Legal | Partner of Research4Life • CrossRef • ORCID • FAIRSharing R.templateTests.simpleTemplate = R.template(' $text $text $text $text $text '); R.templateTests.runTests(); var F1000platform = new F1000.Platform({ name: \"f1000research\", displayName: \"F1000Research\", hostName: \"f1000research.com\", id: \"1\", editorialEmail: \"research@f1000.com\", infoEmail: \"info@f1000.com\", usePmcStats: true }); $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');}); // $(function(){R.ui.dropdowns('.dropdown-for-referees');}); $(document).ready(function () { if ($(\".cookie-warning\").is(\":visible\")) { $(\".sticky\").css(\"margin-bottom\", \"35px\"); $(\".devices\").addClass(\"devices-and-cookie-warning\"); } $(\".cookie-warning .close-button\").click(function (e) { $(\".devices\").removeClass(\"devices-and-cookie-warning\"); $(\".sticky\").css(\"margin-bottom\", \"0\"); }); $(\"#tweeter-feed .tweet-message\").each(function (i, message) { var self = $(message); self.html(linkify(self.html())); }); $(\".partner\").on(\"mouseenter mouseleave\", function() { $(this).find(\".gray-scale, .colour\").toggleClass(\"is-hidden\"); }); }); <!-- Sign in --> Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $(\"a[id=googleSignInButton]\").click(function(event){ event.preventDefault(); $(\"input[id=oAuthSystem]\").val(\"GOOGLE\"); $(\"form[id=oAuthForm]\").submit(); }); $(\"a[id=facebookSignInButton]\").click(function(event){ event.preventDefault(); $(\"input[id=oAuthSystem]\").val(\"FACEBOOK\"); $(\"form[id=oAuthForm]\").submit(); }); $(\"a[id=orcidSignInButton]\").click(function(event){ event.preventDefault(); $(\"input[id=oAuthSystem]\").val(\"ORCID\"); $(\"form[id=oAuthForm]\").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($(\"#sign-in-form-gfb-popup\")); $(\".target-field\").each(function () { var uris = $(this).val().split(\"/\"); if (uris.pop() === \"login\") { $(this).val(uris.toString().replace(\",\",\"/\")); } }); });","source_license":"CC-BY-4.0","license_restricted":false}